UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D. C. 20549

 


 

FORM 10-Q

 


 

Quarterly report pursuant to Section 13 or15(d) of the Securities and Exchange Act of 1934

 

For the quarterly period ended March 31, 2024

 

Transition report pursuant to Section 13 or 15(d) of the Exchange Act

 

For the transition period from                                   to                                 .

 

Commission File Number: 0-9376

innovfood20240331_10qimg001.jpg

 

INNOVATIVE FOOD HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Florida

(State or Other Jurisdiction of Incorporation or Organization)

20-1167761

(IRS Employer I.D. No.)

 

9696 Bonita Beach Rd., Ste. 208, Bonita Springs, Florida 34135

(Address of Principal Executive Offices)

 

(239) 596-0204

(Registrant’s Telephone Number, Including Area Code)

 

                                                                                                                          

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

N/A

 

N/A

 

N/A

 

 

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

(Check One):

Large Accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Regulation 12b-2 of the Exchange Act): Yes ☐ No

 

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 49,693,803 shares of common stock outstanding as of May 13, 2024.

 

 

 

 

INNOVATIVE FOOD HOLDINGS, INC.

TABLE OF CONTENTS TO FORM 10-Q

 

 

 

Page

PART I.

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Consolidated Financial Statements (unaudited)

4

 

Consolidated Balance Sheets

4

 

Consolidated Statements of Operations

5

 

Consolidated Statement of Stockholders’ Equity

6

 

Consolidated Statements of Cash Flows

7

 

Condensed Notes to the Consolidated Financial Statements

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (including cautionary statement)

26

Item 4.

Controls and Procedures

32

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

33

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

33

Item 3.

Defaults Upon Senior Securities

33

Item 4.

Mine Safety Disclosures

33

Item 5.

Other Information

33

Item 6.

Exhibits

34

 

Signatures

35

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1 - CONSOLIDATED FINANCIAL STATEMENTS

 

Innovative Food Holdings, Inc.

Consolidated Balance Sheets

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 
   

(unaudited)

         

ASSETS

               

Current assets

               

Cash and cash equivalents

  $ 4,272,243     $ 5,327,016  

Accounts receivable, net

    4,109,274       4,307,726  

Inventory, net

    2,840,682       2,973,134  

Other current assets

    348,926       287,528  

Assets held for sale

    5,941,933       649,884  

Current assets - discontinued operations

    20,649       95,861  

Total current assets

    17,533,707       13,641,149  
                 

Property and equipment, net

    974,143       7,000,015  

Right of use assets, operating leases, net

    24,344       28,519  

Right of use assets, finance leases, net

    411,488       436,403  

Tradenames and other unamortizable intangible assets

    217,000       217,000  

Total assets

  $ 19,160,682     $ 21,323,086  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities

               

Accounts payable and accrued liabilities

  $ 3,111,671       6,252,951  

Accrued separation costs, related parties, current portion

    418,635       463,911  

Accrued interest

    93,829       95,942  

Deferred revenue

    1,227,936       1,312,837  

Stock appreciation rights liability

    373,918       255,020  

Notes payable - current portion

    100,237       121,041  

Lease liability - operating leases, current

    17,422       17,131  

Lease liability - finance leases, current

    136,096       115,738  

Current liabilities - discontinued operations

    2,522       6,422  

Total current liabilities

    5,482,266       8,640,993  
                 

Note payable, net of discount

    8,501,474       8,855,000  

Accrued separation costs, related parties, non-current

    707,692       791,025  

Lease liability - operating leases, non-current

    6,922       11,388  

Lease liability - finance leases, non-current

    148,931       219,266  

Total liabilities

    14,847,285       18,517,672  
                 

Commitments & Contingencies (see note 18)

               

Stockholders' equity

               

Common stock: $0.0001 par value; 500,000,000 shares authorized; 52,516,974 and 52,538,100 shares issued, and 49,693,803 and 49,714,929 shares outstanding at March 31, 2024 and December 31, 2023, respectively

    5,249       5,251  

Additional paid-in capital

    42,844,922       42,762,811  

Treasury stock: 2,623,171 shares outstanding at March 31, 2024 and December 31, 2023

    (1,141,370 )     (1,141,370 )

Accumulated deficit

    (37,395,404 )     (38,821,278 )

Total stockholders' equity

    4,313,397       2,805,414  
                 

Total liabilities and stockholders' equity

  $ 19,160,682     $ 21,323,086  

 

See condensed notes to these unaudited consolidated financial statements.

 

 

Innovative Food Holdings, Inc.

Consolidated Statements of Operations

(unaudited)

 

   

For the Three

   

For the Three

 
   

Months Ended

   

Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 
                 

Revenue

    15,730,113       16,674,759  

Cost of goods sold

    11,895,799       12,900,609  

Gross margin

    3,834,314       3,774,150  
                 

Selling, general and administrative expenses

    4,013,427       4,444,394  

Separation costs - executive officers

    -       1,945,650  

Total operating expenses

    4,013,427       6,390,044  
                 

Operating (loss)

    (179,113 )     (2,615,894 )
                 

Other income (expense):

               

Interest expense, net

    (215,450 )     (172,721 )

Gain on sale of assets

    1,807,516       -  

Gain on sale of subsidiary

    21,126       -  

Other leasing income

    1,900       1,900  

Total other income (expense)

    1,615,092       (170,821 )
                 

Net income (loss) before taxes

    1,435,979       (2,786,715 )
                 

Income tax expense

    -       -  
                 

Net income (loss) from continuing operations

  $ 1,435,979     $ (2,786,715 )
                 

Net (loss) from discontinued operations

  $ (10,105 )   $ (42,051 )
                 

Consolidated net income (loss)

  $ 1,425,874     $ (2,828,766 )
                 

Net income (loss) per share from continuing operations - basic

  $ 0.029     $ (0.06 )
                 

Net income (loss) per share from continuing operations - diluted

  $ 0.028     $ (0.06 )
                 

Net income (loss) per share from discontinued operations - basic

  $ (0.00 )   $ (0.00 )
                 

Net income (loss) per share from discontinued operations - diluted

  $ (0.00 )   $ (0.00 )
                 

Weighted average shares outstanding - basic

    49,707,036       48,462,234  
                 

Weighted average shares outstanding - diluted

    50,603,891       48,462,234  

 

See condensed notes to these unaudited consolidated financial statements.

 

 

Innovative Food Holdings, Inc.

Consolidated Statements of Stockholders' Equity

Three Months Ended March 31, 2024 and 2023

(unaudited)

 

   

Common Stock

   

Common Stock

to be issued

   

Additional Paid-in

   

Treasury Stock

   

Accumulated

         
   

Amount

   

Value

   

Amount

   

Value

   

Capital

   

Amount

   

Value

   

Deficit

   

Total

 
                                                                         

Balance - December 31, 2022

    49,427,297     $ 4,938       1,499,940     $ 150     $ 42,189,471       2,623,171     $ (1,141,370 )   $ (34,466,126 )   $ 6,587,063  

Shares issued for compensation

    -       -       207,274       20       45,660       -       -       -       45,680  

Shares issued to management and employees, previously accrued

    875,000       87       (875,000 )     (87 )     -       -       -       -       -  

Fair value of shares under compensation plan

    -       -       -       -       20,199       -       -       -       20,199  

Common stock issued for services

    267,030       27       -       -       112,142       -       -       -       112,142  

Net loss for the three months ended March 31, 2023

    -       -       -       -       -       -       -       (2,828,766 )     (2,828,766 )

Balance - March 31, 2023

    50,569,327     $ 5,052       832,214     $ 83     $ 42,367,472       2,623,171     $ (1,141,370 )   $ (37,294,892 )   $ 3,936,345  
                                                                         

Balance - December 31, 2023

    52,538,100     $ 5,251       -       -     $ 42,762,811       2,623,171     $ (1,141,370 )   $ (38,821,278 )   $ 2,805,414  

Shares returned to treasury from sale of subsidiary

    (21,126 )     (2 )     -       -       (21,124 )     -       -       -       (21,126 )

Fair value of shares under compensation plan

    -       -       -       -       103,235       -       -       -       103,235  

Net income for the three months ended March 31, 2024

    -       -       -       -       -       -       -       1,425,874       1,425,874  

Balance - March 31, 2024

    52,516,974     $ 5,249       -     $ -     $ 42,844,922       2,623,171     $ (1,141,370 )   $ (37,395,404 )   $ 4,313,397  

 

See condensed notes to these unaudited consolidated financial statements.

 

 

Innovative Food Holdings, Inc.

Consolidated Statements of Cash Flows

 

   

For the Three

   

For the Three

 
   

Months Ended

   

Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Cash flows from operating activities:

               

Net income (loss)

  $ 1,425,874     $ (2,828,766 )

Adjustments to reconcile net income (loss) to net cash used in operating activities:

               

Gain on disposition of asset

    (1,807,516 )     -  

Gain on sale of subsidiary

    (21,126 )     -  

Depreciation and amortization

    110,260       145,387  

Amortization of right of use asset

    4,175       16,314  

Amortization of discount on notes payable

    1,283       -  

Stock based compensation

    103,235       178,048  

Loss on value of stock appreciation rights

    118,898       -  

Provision for doubtful accounts

    22,882       4,666  
                 

Changes in assets and liabilities:

               

Accounts receivable, net

    175,436       135,020  

Inventory and other current assets, net

    71,054       (51,038 )

Accounts payable and accrued liabilities

    (3,144,335 )     (2,056,459 )

Accrued separation costs - related parties

    (128,610 )     1,600,795  

Deferred revenue

    (84,548 )     (319,365 )

Operating lease liability

    (4,175 )     (16,314 )

Net cash used in operating activities

    (3,157,213 )     (3,191,712 )
                 

Cash flows from investing activities:

               

Acquisition of property and equipment

    (1,406 )     (7,995 )

Cash received from disposition of asset, net of loan payoff

    2,101,185       -  

Net cash from (used in) investing activities

    2,099,779       (7,995 )
                 

Cash flows from financing activities:

               

Principal payments on debt

    (22,708 )     (2,757 )

Principal payments financing leases

    (49,977 )     (46,807 )

Net cash (used in) financing activities

    (72,685 )     (49,564 )
                 

Decrease in cash and cash equivalents

    (1,130,119 )     (3,249,271 )
                 

Cash and cash equivalents at beginning of period

    5,422,335       4,899,398  
                 

Cash and cash equivalents at end of period - continuing operations

  $ 4,272,243     $ 1,435,561  

Cash and cash equivalents at end of period - discontinued operations

  $ 19,973     $ 214,566  

Cash and cash equivalents at end of period

  $ 4,292,216     $ 1,650,127  
                 

Supplemental disclosure of cash flow information:

               
                 

Cash paid during the period for:

               

Interest

  $ 228,970     $ 174,410  
                 

Taxes

  $ -     $ -  
                 

Non-cash investing and financing activities:

               

Reclassify fixed assets as held for sale

  $ 5,941,933     $ -  

Principal and accrued interest paid from escrow to Maple Mark Bank

  $ 353,815     $ -  

 

See condensed notes to these unaudited consolidated financial statements.

 

 

INNOVATIVE FOOD HOLDINGS, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(Unaudited)

 

1. NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements include those of Innovative Food Holdings, Inc. and all of its wholly-owned subsidiaries (collectively, the “Company”) and have been prepared in accordance with generally accepted accounting principles pursuant to Regulation S-X of the Securities and Exchange Commission and with the instructions to Form 10-Q. Certain information and footnote disclosures normally included in audited consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Accordingly, these interim financial statements should be read in conjunction with the Company’s audited financial statements and related notes as contained in Form 10-K for the year ended December 31, 2023. In the opinion of management, the interim unaudited consolidated financial statements reflect all adjustments, including normal recurring adjustments, necessary for fair presentation of the interim periods presented. The results of the operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full year.

 

Business Activity

 

We provide difficult-to-find specialty foods primarily to both Professional Chefs and Home Gourmets through our relationships with producers, growers, makers and distributors of these products worldwide. The distribution of these products primarily originates from our three unified warehouses and those of our drop ship partners, and is driven by our proprietary technology platform. In addition, we provide value-added services through our team of food specialists and Chef Advisors who offer customer support, menu ideas, and preparation guidance.

 

Restructuring

 

During the fourth quarter of 2023 we made the decision to focus more on our Business to Business (B2B) activities and less on our Direct to Consumer (D2C) products. Our subsidiaries GROW and Oasis were sold effective December 29, 2023; Haley was sold effective February 26, 2024; and the activities of P Innovations will be abandoned. Our remaining D2C business, primarily operated within igourmet and Mouth, will be downsized. See note 2.

 

Discontinued Operations

 

Pursuant to the guidance of ASC 205-20 Presentation of Financial Statements Discontinued Operations, the accounts of our discontinued entities GROW, Oasis, Haley, and P Innovations have been included in “Net loss from discontinued operations” in our consolidated statements of operations until such time as each entity was sold. Additionally, the assets and liabilities of these entities have been presented as discontinued operations in our consolidated balance sheets as of March 31, 2024 and December 31, 2023 until such time as each entity was sold. See Note 2.

 

Reclassifications

 

Certain amounts presented in the financial statements of the prior period have been reclassified to conform with the current period presentation of discontinued operations. See note 2.

 

Use of Estimates

 

The preparation of these unaudited consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, inventory reserves, income taxes, intangible assets, operating and finance right of use assets and liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

 

 

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash in investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limit. At March 31, 2024 and 2023, trade receivables from the Company’s largest customer amounted to 32% and 23%, respectively, of total trade receivables. During the three months ended March 31, 2024 and 2023, sales from the Company’s largest customer amounted to 49% and 47% of total sales, respectively.

 

The Company maintains cash balances in excess of Federal Deposit Insurance Corporation limits. At March 31, 2024 and December 31, 2023, the total cash in excess of these limits was $931,857 and $988,825, respectively.

 

Accounts Receivable

 

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts pursuant to the guidance of Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326) as codified in Accounts Standards Codification (ASC) 326, Financial Instruments – Credit Losses. Under ASC 326, the Company utilizes a current and expected credit loss (CECL) impairment model. ASU 2016-13 became effective for us on January 1, 2023. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. Accounts receivable are presented net of an allowance for doubtful accounts of $69,359 and $46,477 at March 31, 2024 and December 31, 2023, respectively.

 

Leases

 

The Company accounts for leases in accordance with Financial Accounting Standards Board (“FASB”) ASC 842, “Leases”. The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets (“ROU assets”) and short-term and long-term lease liabilities are included on the face of the consolidated balance sheet. Finance lease ROU assets are presented within other assets, and finance lease liabilities are presented within current and long-term liabilities.

 

ROU assets represent the right of use to an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For lease agreements with terms less than 12 months, the Company has elected the short-term lease measurement and recognition exemption, and it recognizes such lease payments on a straight-line basis over the lease term.

 

Revenue Recognition

 

The Company recognizes revenue upon product delivery. All of our products are shipped either same day or overnight or through longer shipping terms to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues.

 

For revenue from product sales (i.e., specialty foodservice and e-commerce), the Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers”. A five-step analysis must be met as outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

 

Warehouse and logistic services revenue is primarily comprised of inventory management, order fulfilment and warehousing services. Warehouse & logistics services revenues are recognized at the point in time when the services are rendered to the customer.

 

 

Deferred Revenue

 

Certain customer arrangements in the Company’s business such as gift cards and e-commerce subscription purchases result in deferred revenues when cash payments are received in advance of performance. Gift cards issued by the Company generally have an expiration of five years from date of purchase. The Company records a liability for unredeemed gift cards and advance payments for monthly club memberships as cash is received, and the liability is reduced when the card is redeemed or product delivered.

 

The following table represents the changes in deferred revenue as reported on the Company’s consolidated balance sheets:

 

Balance as of December 31, 2022

  $ 1,558,155  

Cash payments received

    215,346  

Net sales recognized

    (534,711 )

Balance as of March 31, 2023 (unaudited)

  $ 1,238,790  

 

Balance as of December 31, 2023

  $ 1,312,837  

Cash payments received

    4,033,077  

Net sales recognized

    (4,117,978 )

Balance as of March 31, 2024 (unaudited)

  $ 1,227,936  

 

Disaggregation of Revenue

 

The following table represents a disaggregation of revenue for the three months ended March 31, 2024 and 2023:

 

   

Three Months Ended

 
   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Specialty Foodservice

  $ 13,993,565     $ 13,804,785  

E-Commerce

    1,528,337       2,621,405  

Logistics

    208,211       248,569  

Total

  $ 15,730,113     $ 16,674,759  

 

Cost of goods sold

 

We have included in cost of goods sold all costs which are directly related to the generation of revenue. These costs include primarily the cost of food and raw materials, packing and handling, shipping, and delivery costs.

 

We have also included all payroll costs as cost of goods sold in our leasing and logistics services business.

 

Basic and Diluted Earnings Per Share

 

Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully-diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during the period.

 

The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation.

 

 

Dilutive shares at March 31, 2024:

 

Stock Options

 

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2024:

 

               

Weighted

 
               

average

 
               

Remaining

 

Exercise

   

Number of

   

contractual

 

Price

   

Options

   

life (years)

 
$ 0.41       125,000       0.07  
$ 0.50       125,000       0.07  
$ 0.60       50,000       1.75  
$ 1.00       50,000       1.75  
$ 1.25       130,000       2.25  
$ 1.75       130,000       2.25  
          610,000       1.27  

 

Restricted Stock Awards

 

At March 31, 2024, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. The fair value of these RSUs at the date of the grants will be charged to operations upon vesting. At March 31, 2024, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2024.

 

Stock-based Compensation

 

At March 31, 2024, there were a total of 3,910,534 shares of common stock potentially issuable to the Company’s executive officers pursuant to compensation plans and contingent upon the achievement of certain performance goals; see notes 15 and 16.

 

Dilutive shares at March 31, 2023:

 

Stock Options

 

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2023:

 

               

Weighted

 
               

Average

 
               

Remaining

 

Exercise

   

Number

   

Contractual

 

Price

   

of Options

   

Life (years)

 
$ 0.41       125,000       1.07  
$ 0.50       125,000       1.07  
$ 0.60       50,000       2.75  
$ 0.62       360,000       0.75  
$ 0.85       540,000       0.75  
$ 1.00       50,000       2.75  
$ 1.20       950,000       0.74  
          2,200,000       0.87  

 

 

Restricted Stock Awards

 

At March 31, 2023, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. At March 31, 2023, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2023.

 

Stock-based Compensation

 

At March 31, 2023, there were a total of 3,538,243 shares of common stock potentially issuable to the Company’s Chief Executive Officer pursuant to his compensation plan and contingent upon the achievement of certain performance goals. see notes 15 and 16.

 

New Accounting Pronouncements

 

Management does not believe that any other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

 

2. DISCONTINUED OPERATIONS

 

During the fourth quarter of fiscal 2023, in connection with an analysis of the Company’s sales mix and profitability by service offering, management made the strategic decision to focus on the Company’s Business to Business (B2B) service offering and to allocate fewer resources to and in some cases to sell certain of the Company’s subsidiaries involved in our Direct to Consumer (D2C) service offerings. Pursuant to this strategy, on December 29, 2023, the Company completed the sales of its Grow and Oasis subsidiaries, and on February 26, 2024, the Company completed the sale of its Haley subsidiary (see note 3). In addition, the operations of P Innovations has been abandoned.

 

The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 

Current assets - discontinued operations:

 

(unaudited)

         

Cash

  $ 19,973     $ 95,319  

Accounts receivable

    635       501  

Inventory

    41       41  

Other current assets

    -       -  

Total current assets - discontinued operations

  $ 20,649     $ 95,861  
                 

Current liabilities - discontinued operations:

               

Accounts payable and accrued liabilities

  $ -     $ 986  

Accrued payroll and related liabilities

    -       3,267  

Deferred revenue

    2,522       2,169  

Total current liabilities - discontinued operations

  $ 2,522     $ 6,422  

 

The following information presents the major classes of line items constituting the after-tax loss from discontinued operations in the consolidated statements of operations:

 

   

Three Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 

Revenue

  $ 24,856     $ 320,441  

Cost of goods sold

    (2,238 )     (8,080 )

Gross margin

    22,618       312,361  
                 

Selling, general, and administrative expenses

    (32,723 )     (354,692 )
                 

Interest income

    -       280  

Loss from discontinued operations, net of tax

  $ (10,105 )   $ (42,051 )

 

 

There were no major classes of line items which constituted significant operating and investing cash flow activities in the consolidated statements of cash flows relating to discontinued operations.

 

3. SALE OF SUBSIDIARY

 

On February 26, 2024, the Company sold 100% of the equity interests in Haley Food Group, Inc., (“Haley”) for the return of 21,126 shares of the Company’s common stock held by the buyer. The Company Haley had no assets of liabilities at the time of the sale; the Company valued the 21,126 shares of common stock at the market price on the date of the acquisition of $1.00 per sale and recorded a gain in the amount of $21,126 on this transaction.

 

4. ACCOUNTS RECEIVABLE

 

At March 31, 2024 and December 31, 2023, accounts receivable consists of:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Accounts receivable from customers

  $ 4,178,633     $ 4,354,203  
Allowance for doubtful accounts     (69,359 )     (46,477 )

Accounts receivable, net

  $ 4,109,274     $ 4,307,726  

 

During the three months ended March 31, 2024 and 2023, the Company charged the amount of $22,882 and $4,666 to provision for credit loss, respectively.

 

5. INVENTORY

 

Inventory consists primarily of specialty food products. At March 31, 2024 and December 31, 2023, inventory consisted of the following:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Finished goods inventory

  $ 2,840,682     $ 2,973,134  

Allowance for slow moving & obsolete inventory

    -       -  

Finished goods inventory, net

  $ 2,840,682     $ 2,973,134  

 

6. PROPERTY AND EQUIPMENT

 

A summary of property and equipment at March 31, 2024 and December 31, 2023 is as follows:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Land

  $ 208,140     $ 1,079,512  

Building

    711,409       6,571,496  

Computer and Office Equipment

    599,242       597,834  

Warehouse Equipment

    477,090       477,090  

Furniture and Fixtures

    940,960       940,960  

Vehicles

    58,353       58,353  

Total before accumulated depreciation

    2,995,194       9,725,245  

Less: accumulated depreciation

    (2,021,051 )     (2,725,230 )

Total

  $ 974,143     $ 7,000,015  

 

Depreciation expense for property and equipment amounted to $85,345 and $101,576 for the three months ended March 31, 2024 and 2023, respectively. Depreciation expense for property and equipment is recorded in selling, general & administrating expenses on the Company’s statement of operations. During the three months ended March 31, 2024 and 2023, the Company acquired property and equipment in the amount of $1,406 and $7,995, respectively.

 

 

7. PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE

 

Assets held for sale include the net book value of property and equipment the Company plans to sell within the next year. Long lived assets that meet the criteria are held for sale and reported at the lower of their carrying value or fair value less estimated cost to sell.

 

As of December 31, 2023, the Company classified the land, building, leasehold improvements, and certain equipment located at 28411 Race Track Road, Bonita Springs, Florida, 34135 (the “Race Track Road Property”) as held for sale. On February 14, 2024, the Company finalized the sale of the Race Track Road Property for cash in the amount of $2,455,000. The Company recorded a gain on the sale in the amount of $1,807,516. Proceeds of the sale in the amount of $353,815 were used to pay the mortgage and accrued interest on the Race Track Road Property. Total expenses related to the sale $165,755, including a commission of $147,300, state taxes of $17,185, and closing fees of $1,270.

 

As of March 31, 2024, the Company classified the land and building located at 220 Oak Hill Road, Mountain Top, Pennsylvania, as held for sale.

 

The net book value of these assets consisted of the following at March 31, 2024 and December 31, 2023:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 
                 

Land

  $ 871,372     $ 177,383  

Building

    5,070,561       431,147  

Furniture, fixtures, and equipment

    -       41,314  

Total

  $ 5,941,933     $ 649,844  

 

8. RIGHT OF USE (ROU) ASSETS AND LEASE LIABILITIES OPERATING LEASES

 

The Company has operating leases for offices, warehouses, vehicles, and office equipment. The Company’s leases have remaining lease terms of 1 year to 3 years, some of which include options to extend.

 

The Company’s lease expense for the three months ended March 31, 2024 and 2023 was entirely comprised of operating leases and amounted to $8,165 and $18,790, respectively.

 

The Company’s ROU asset amortization for the three months ended March 31, 2024 and 2023 was $4,175 and $16,314, respectively. The difference between the lease expense and the associated ROU asset amortization consists of interest.

 

Right of use assets – operating leases are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Right of use assets, net

  $ 24,344     $ 28,519  

 

Operating lease liabilities are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Lease liability

  $ 24,344     $ 28,519  

Less: current portion

    (17,422 )     (17,131 )

Lease liability, non-current

  $ 6,922     $ 11,388  

 

 

Maturity analysis under these lease agreements are as follows:

 

For the period ended March 31, 2025

  $ 18,532  

For the period ended March 31, 2026

    7,051  

Total

  $ 25,583  

Less: Present value discount

    (1,239 )

Lease liability

  $ 24,344  

 

9. RIGHT OF USE ASSETS FINANCING LEASES

 

The Company has financing leases for vehicles and warehouse equipment. Right of use asset – financing leases are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Vehicles

  $ 404,858     $ 404,858  

Warehouse Equipment

    555,416       555,416  

Total before accumulated depreciation

    960,274       960,274  

Less: accumulated depreciation

    (548,786 )     (523,871 )

Total

  $ 411,488     $ 436,403  

 

Depreciation expense related to right of use assets for the three months ended March 31, 2024 and 2023 was $24,915 and $33,480, respectively.

 

Financing lease liabilities are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a forklift dated July 12, 2021 in the original amount of $16,070 payable in thirty-six monthly installments of $489 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $1,431 and $36, respectively.

  $ 1,453     $ 2,884  
                 

Financing lease obligation under a lease agreement for a pallet truck dated July 15, 2021 in the original amount of $5,816 payable in thirty-six monthly installments of $177 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $518 and $13, respectively.

  $ 526     $ 1,044  
                 

Financing lease obligation under a lease agreement for warehouse furniture and equipment truck dated October 14, 2020 in the original amount of $514,173 payable in sixty monthly installments of $9,942 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amount of $19,084 and $2,834, respectively.

  $ 170,712     $ 197,707  

 

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a truck dated March 31, 2020 in the original amount of $152,548 payable in eighty-four monthly installments of $2,188 including interest at the rate of 5.44%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,552 and $1,012, respectively.

  $ 70,666     $ 76,218  
                 

Financing lease obligation under a lease agreement for a truck dated November 5, 2018 in the original amount of $128,587 payable in seventy monthly installments of $2,326 including interest at the rate of 8.33%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $6,647 and $330, respectively.

    11,388     $ 18,035  
                 

Financing lease obligation under a lease agreement for a truck dated August 23, 2019 in the original amount of $80,413 payable in eighty-four monthly installments of $1,148 including interest at the rate of 5.0%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $3,040 and $404, respectively.

  $ 30,282     $ 33,322  
                 

Financing lease obligation under a lease agreement for a truck dated February 4, 2022 in the original amount of $42,500 payable in twenty-four monthly installments of $1,963 including interest at the rate of 10.1%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,794 and $98, respectively.

  $ -     $ 5,794  
                 

Total

  $ 285,027     $ 335,004  
                 

Current portion

  $ 136,096     $ 115,738  

Long-term maturities

    148,931       219,266  

Total

  $ 285,027     $ 335,004  

 

There was no accrued interest on financing leases at March 31, 2024 and December 31, 2023.

 

Aggregate maturities of lease liabilities:

 

For the twelve months ended March 31,

 

2025

  $ 160,993  

2026

    96,060  

2027

    27,974  

Total

  $ 285,027  

 

10. INTANGIBLE ASSETS

 

The Company acquired certain intangible assets pursuant to the acquisitions of Artisan, Oasis, igourmet, OFB, Haley, and Mouth. These assets include non-compete agreements, customer relationships, trade names, internally developed technology, and goodwill. The Company has also capitalized the development of its website.

 

Other Non-Amortizable Intangible Assets

 

Other non-amortizable intangible assets consist of $217,000 of trade names held by Artisan. The Company followed the guidance of ASC 360 “Property, Plant, and Equipment” (“ASC 360”) in assessing these assets for impairment. ASC 360 states that impairment testing should be completed whenever events or changes in circumstances indicate the asset’s carrying value may not be recoverable. In management’s judgment there are no indications that the carrying value of these trade names may not be recoverable, and it determined that impairment testing was not required.

 

 

The Company acquired certain intangible assets pursuant to the acquisitions through Artisan. The following is the net book value of these assets:

 

   

March 31, 2024

(unaudited)

 
           

Accumulated

         
   

Gross

   

Amortization

   

Net

 

Trade Names

  $ 217,000     $ -     $ 217,000  

 

   

December 31, 2023

 
           

Accumulated

         
   

Cost

   

Amortization

   

Net

 

Total Trade Names

  $ 217,000     $ -     $ 217,000  

 

Total amortization expense for the three months ended March 31, 2024 and 2023 was $0.

 

11. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable and accrued liabilities at March 31, 2024 and December 31, 2023 are as follows:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Trade payables and accrued liabilities

  $ 2,955,157     $ 6,046,396  

Accrued payroll and commissions

    156,514       206,555  

Total

  $ 3,111,671     $ 6,252,951  

 

12. ACCRUED SEPARATION COSTS RELATED PARTIES

 

On February 3, 2023, the Company entered into a Severance Note, an Agreement and General Release, and a Side Letter thereto with Sam Klepfish (the “SK Agreements”), its prior CEO and a current board member. The SK Agreements provide, among other things, for Mr. Kelpfish’s resignation from all positions with the Company and its subsidiaries on February 28, 2023, except that Mr. Klepfish will remain a director and member of the board of the Company, confidentiality and non-disparagement conditions, nomination of Mr. Klepfish for future election to the board of directors at least through the 2024 general meeting of shareholders based on certain minimum stock ownership and Board Observer rights when Mr. Klepfish is no longer a director but maintains certain minimum agreed upon stock ownership. The payment terms are $250,000 upon effectiveness and an additional $1,000,000 payable in weekly payments of $6,410.26 from March 8, 2023 through March 6, 2026. The $250,000 was paid into an escrow account with the requirement that they are released to Mr. Klepfish on his separation date. The $1,000,000 portion is in the form of an unsecured, non-interest bearing note payable to Mr. Klepfish. The SK Agreements also call for the delivery of 400,000 shares of the Company’s common stock valued at $168,000 based upon the closing price of the Company’s common stock on Mr. Klepfish’s separation date of February 28, 2023; in addition, for delivery on June 1, 2027 of additional shares of the Company’s common stock equal to the greater of (i) the number of shares with an aggregate fair market value of $400,000 on such date, or (ii) 266,666 shares. The Company also agreed to pay a total of $1,199 of Cobra insurance costs on behalf of Mr. Klepfish over eighteen months. The total amount accrued in connection with the SK Agreements was $1,819,199.

 

On February 28, 2023, the Company entered into a separation agreement (the “Wiernasz Separation Agreement”) with Justin Wiernasz, a director and previous Director of Strategic Acquisitions. Pursuant to the Wiernasz Separation Agreement, the Company agreed to a payment of $100,000 in cash as follows: $33,333 upon execution of the agreement, $33,333 on March 15, 2023, and $33,334 on April 15, 2023. The Company also agreed to make the Cobra insurance payments on behalf of Mr. Wiernasz in the amount of $2,548 per month for twelve months with a maximum of $26,451. The total amount accrued in connection with the Wiernasz Separation Agreement was $126,451.

 

 

On February 6, 2024, the Company entered into a separation agreement with Richard Tang, its Chief Financial Officer (the “Tang Separation Agreement”) effective as of December 31, 2023. Pursuant to the Tang Separation Agreement, the Company will pay to Mr. Tang, in equal installments over a five month period, the gross sum of $113,918. In addition, Mr. Tang may submit for reimbursement up to $4,000 of legal expenses connected with the review of this separation agreement. The severance payment will be made in the following installments: (i) $25,890 to be paid the week of March 4, 2024; (ii) $5,178 to be paid each successive week for seventeen weeks beginning the week of March 11, 2024, until the Severance Payment is completed. In addition, if Tang timely elects to continue his group health insurance benefits under the Consolidated Omnibus Reconciliation Act (“COBRA”), the Company will reimburse Tang’s group health insurance premiums (“COBRA Premiums”) for the lesser of: (a) the period of time Employee is eligible to continue his group health insurance benefits under COBRA and (b) the five-month period immediately following the Separation Date. Reimbursements will be paid within thirty days of when Tang submits a request for reimbursement and supporting documentation.

 

During the three months ended March 31, 2024, the Company paid cash in the amount of $83,333 to Mr. Klepfish in connection with the SK Agreements.

 

During the three months ended March 31, 2024, the Company made the following payments in connection with the Wiernasz Separation Agreement: The Company made Cobra payments on behalf of Mr. Weirnasz in the amount of $967.

 

During the three months ended March 31, 2024, the Company made the following payments in connection with the Tang Separation agreement: The Company paid cash to Mr. Tang in the amount of $41,125, and made Cobra payments on behalf of Mr. Tang in the amount of $2,885.

 

The following table represents the amounts accrued, paid, and outstanding on these agreements as of March 31, 2024:

 

   

Total

   

Paid / Issued

   

Balance

   

Current

   

Non-current

 

Mr. Klepfish:

                                       

Cash – through March 6, 2026

  $ 1,000,000     $ (358,975 )   $ 641,025     $ 333,333     $ 307,692  

Cash - upon agreement execution

    250,000       (250,000 )     -       -       -  

Stock - June 1, 2027

    400,000       -       400,000       -       400,000  

Stock - Issued in April 2023

    168,000       (168,000 )     -       -       -  

Cobra - over eighteen months

    1,199       -       1,199       1,199       -  

Total – Mr. Klepfish

  $ 1,819,199     $ (776,975 )   $ 1,042,224     $ 334,532     $ 707,692  
                                         

Mr. Wiernasz:

                                       

Cash - three equal payments

  $ 100,000     $ (100,000 )   $ -     $ -     $ -  

Cobra - over eighteen months

    26,451       (26,451 )     -       -       -  

Total - Mr. Wiernasz

  $ 126,451     $ (126,451 )   $ -     $ -     $ -  
                                         

Mr. Tang:

                                       

Cash – over seventeen weeks

  $ 113,918     $ (41,425 )   $ 72,493     $ 72,493     $ -  

Cobra - over five months

    14,495       (2,885 )     11,610       11,610       -  

Total - Mr. Tang

  $ 128,413     $ (44,310 )   $ 84,103     $ 84,103     $ -  
                                         

Total Company

  $ 2,074,063     $ (947,736 )   $ 1,126,327     $ 418,635     $ 707,692  

 

 

13. STOCK APPRECIATION RIGHTS LIABILITY

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its Chief Operating Officer. See note 15. The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense.

 

The change in valuation of the Smallwood SARs is summarized in the table below:

 

May 15, 2023 - fair value

  $ 9,794  

(Gain) Loss on revaluation

    245,226  

December 31, 2023 -fair value

  $ 255,020  

(Gain) Loss on revaluation

    118,898  

March 31, 2024 - fair value

  $ 373,918  

 

14. NOTES PAYABLE

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 13, 2023, the Company entered into a term loan with MapleMark Bank (the “MapleMark Term Loan 3”) in the amount of $9,057,840. Principal and interest due on the MapleMark Term Loan 1 in the amounts of $5,324,733 and $61,715, respectively, were paid with proceeds of the MapleMark Term Loan 3. The MapleMark Term Loan 3 is payable in monthly installments of $80,025 commencing July 1, 2023 and continuing through June 13, 2048.

 

Amounts outstanding under the Maple Mark Term Loan 3 will bear interest at the rate equal to the lesser of (a) the Maximum Lawful Rate, or (b) the greater of (i) WSJP (the “Prime Rate” as published by The Wall Street Journal) plus 1.25% per annum or (ii) 4.50% per annum. At March 31, 2024, the interest rate was 9.50%. The MapleMark Term Loan 3 matures on June 13, 2048.

 

The MapleMark Term Loan 3 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens.

 

The Company created a discount on the MapleMark Term Loan 3 for costs in the amount of $385,803 which will be amortized over the life of the loan. During the three months ended March 31, 2024, the Company amortized $1,284 of these costs to interest expense. During the three months ended March 31, 2024, the Company made principal payments and interest payments in the amount of $22,709 and $221,317, respectively, on this loan. At March 31, 2024, accrued interest on this note was $75,251.

  $ 8,962,933     $ 8,985,642  

 

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 6, 2022, the Company entered into a term loan agreement with MapleMark (the “MapleMark Term Loan 2”) for the original amount of $356,800. This amount was paid by MapleMark directly to Fifth Third Bank in satisfaction of the outstanding principal and interest due under existing loans with Fifth Third Bank. The MapleMark Term Loan 2 originally matured on May 27, 2023. On June 9, 2023, the USDA approved the Guarantee of MapleMark Term Loan 1 which allowed the Company to extend the term of the MapleMark Term Loan 2 from May 27, 2023 to May 27, 2033 with monthly payments in the amount of approximately $2,311 commencing July 1, 2023 and continuing through June 1, 2033. On July 1, 2033, a final payment in the amount of approximately $303,536 will be due on the MapleMark Term Loan 2.

 

The MapleMark Term Loan 2 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens. The Company recorded a discount to this loan in the amount of $23,367 in connection with financing costs which was amortized to interest expense during the year ended December 31, 2022.

 

On February 14, 2024, The Company sold its Race Track Road Facility in Bonita Springs, Florida, which had been pledged as security for the MapleMark Term Loan 2 (see note 7). Proceeds from the sale in the amount of $352,905 and $910 were used to pay the remaining principal and interest, respectively, on the MapleMark Term Loan 2. At March 31, 2024, there are no amounts due under the MapleMark Term Loan 2.

  $ -     $ 352,905  
                 

A note payable in the amount of $20,000. The Note was due in January 2006 and the Company is currently accruing interest on this note at 1.9%. During the three months ended March 31, 2024, the Company accrued interest in the amount of $96 on this note. At March 31, 2024, accrued interest on this note was $18,578.

  $ 20,000     $ 20,000  

 

Total

  $ 8,982 933     $ 9,358,547  

Discount

    (381,222 )     (382,506 )

Net of discount

  $ 8,601,711     $ 8,976,041  
                 

Current portion

  $ 100,237     $ 121,041  

Long-term maturities, net of discount

    8,501,474       8,855,000  

Total

  $ 8,601,711     $ 8,976,041  

 

There was a total of $93,829 and $95,942 accrued interest on notes payable at March 31, 2024 and December 31, 2023, respectively.

 

 

Aggregate maturities of notes payable as of March 31, 2024 are as follows:

 

For the period ended March 31,

 

2025

  $ 120,237  

2026

    110,532  

2027

    121,884  

2028

    134,403  

2029

    148,207  

Thereafter

    8,347,670  

Total

  $ 8,982,933  

 

15. EQUITY

 

Common Stock

 

As of March 31, 2024, total common stock issued and outstanding was 52,516,974 and 49,693,803, respectively. As of December 31, 2023, total common stock issued and outstanding was 52,538,100 and 49,714,929, respectively. At March 31, 2024 and December 31, 2023, a total of 2,823,171 shares of common stock were deemed issued but not outstanding.

 

For the three months ended March 31, 2024:

 

Common Stock Received from Sale of Subsidiary

 

On February 26, 2024, the Company sold 100% of the equity interests in Haley for the return of 21,126 shares of the Company’s common stock held by the buyer. (see note 3). The Company Haley had no assets of liabilities at the time of the sale; the Company valued the 21,126 shares of common stock at the market price on the date of the acquisition of $1.00 per sale and recorded a gain in the amount of $21,126 on this transaction.

 

For the three months ended March 31, 2023:

 

On February 28, 2023, the Company issued 267,030 shares with a value of $112,152 to three employees as compensation.

 

During the three months ended March 31, 2023, the Company incurred obligations to issue the following shares of common stock pursuant to employment agreements: an aggregate total of 400,007 shares of common stock with a market value of $93,600 were accrued for issuance to its previous Chief Executive Officer; of this amount, 207,839 with a market value of $52,919 were withheld for the payment of income taxes, and the net number of shares issuable to the previous Chief Executive Officer was 192,168 with a market value of $45,680. Also during the period, an aggregate total of 15,106 shares of common stock with a market value of $5,000 were accrued for issuance to two board members, and $19,428 was expensed during the quarter for the share based plan for the Chief Executive Officer (see below). These restricted stock grants are being amortized over their vesting periods of one to three years. During the three months ended March 31, 2023, the total amount of $178,048 was charged to non-cash compensation and $52,919 was charged to cash compensation in connection with these grants.

 

 

Share based executive compensation plans

 

CEO Stock Plan

 

On February 3, 2023, the Company entered into an employment agreement with Bill Bennett to become the Company’s CEO. On November 3, 2023, the Company recognized that the hiring of Mr. Bennett was protracted, and the original employment agreement calculated the number of Shares to be granted in connection with the Executive Compensation Plan on the basis of the number of Shares outstanding as of October 2022, which did not take into consideration the number of shares that were issued to a departing executive and to certain other employees of the Company thereafter. Accordingly, the number of shares issuable to Mr. Bennett at each price target was adjusted, effective as of the original date of the plan. Pursuant to this agreement, Mr. Bennett was provided with an incentive compensation plan (the “CEO Stock Plan”) whereby Mr. Bennett would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.60       2.00 %     975,133  
$ 0.80       1.50 %     731,350  
$ 1.00       1.00 %     487,567  
$ 1.20       0.75 %     365,675  
$ 1.40       0.75 %     365,675  
$ 1.60       0.50 %     243,783  
$ 1.80       0.50 %     243,783  
$ 2.00       0.50 %     243,783  

 

The value of the plan was determined to be $660,541. This amount will be recorded as a charge to additional paid-in capital on a straight-line basis over 34 months. During the three months ended March 31, 2024, the amounts of $58,283 was charged to operations pursuant to the CEO Stock Plan.

 

On November 7, 2023, the Company issued 678,302 shares of common stock, net of 296,831 shares withheld for income tax purposes, to its Chief Executive Officer pursuant the achievement of the first price target in the CEO Stock Plan.

 

On March 19, 2024, the Company’s stock price attained the second price target in the CEO Stock Plan, and Mr. Bennett became eligible to receive 731,350 shares of the Company’s common stock. These shares have not been issued as of March 31, 2024.

 

COO Stock Plan

 

On April 14, 2023, the Company entered into an employment agreement with Brady Smallwood to become the Company’s COO effective May 15, 2023. Pursuant to this agreement, Mr. Smallwood was provided with an incentive compensation plan (the “COO Stock Plan”) whereby Mr. Smallwood would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.87       0.40 %     196,627  
$ 1.16       0.30 %     147,470  
$ 1.45       0.20 %     98,313  
$ 1.74       0.15 %     73,735  
$ 2.03       0.15 %     73,735  
$ 2.32       0.10 %     49,157  
$ 2.61       0.10 %     49,157  
$ 2.90       0.10 %     49,157  

 

The value of the plan was determined to be $199,951. This amount will be recorded as a charge to additional paid-in capital on a straight-line basis over 31.5 months. During the three months ended March 31, 2024, the amount of $19,043 was charged to operations pursuant to the COO Stock Plan. At March 31, 2024, none of the price targets under the COO Stock Plan have been achieved.

 

 

CFO Stock Plan

 

On December 29, 2023, the Company entered into an employment agreement with Gary Schubert to become the Company’s CFO effective January 1, 2024. Pursuant to this agreement, Mr. Schubert was provided with an incentive compensation plan (the “CFO Stock Plan”) whereby Mr. Schubert would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 1.23       0.40 %     131,085  
$ 1.63       0.30 %     98,313  
$ 2.04       0.20 %     65,542  
$ 2.45       0.15 %     49,157  
$ 2.86       0.15 %     49,157  
$ 3.27       0.10 %     32,771  
$ 3.68       0.10 %     32,771  
$ 4.08       0.10 %     32,771  

 

The CFO Stock Plan had a fair value of $238,747 at inception (see “Stock Plan Valuation” section below). This amount will be amortized over the 30-month life of the plan beginning January 1, 2024. During the three months ended March 31, 2024, $23,875 of this amount was charged to operations. At March 31, 2024, none of the price targets under the COO Stock Plan have been achieved.

 

The Company relied upon the guidance of Statement of Financial Account Standards No. 718 Compensation – Stock Compensation (“ASC 718”) in accounting for the CEO, COO, and CFO Stock Plans. A Monte Carlo market-based performance stock awards model was used in valuing the plan, with the following assumptions:

 

 

The stock price for each trading day would fluctuate with an estimated projected volatility using a normal distribution. The stock price of the underlying instrument is modeled such that it follows a geometric Brownian motion with constant drift and volatility.

 

 

 

 

The Company would award the stock upon triggering the thresholds.

 

 

 

 

Annual attrition or forfeiture rates (i.e., pre–vesting forfeiture assumption) are assumed to be zero given the Holder’s position with the Company.

 

 

 

 

No Projected capital events were included in the adjustments to the shares issued and outstanding in the projected simulations.

 

 

 

 

Awards/Payouts were discounted at the risk–free rate.

 

The CEO, COO, and CFO Stock Plans were valued utilizing the following:

 

   

December 31, 2023

Volatility

    103.9%-113.7%

Dividends

  $ 0 

Risk-free interest rates

    4.45%-4.45%

Expected term (years)

    2.63-2.91 

 

Stock Appreciation Rights

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its Chief Operating Officer. The Smallwood SARs vest upon issuance, and expire on December 31, 2026; 750,000 of the Smallwood SARs are priced at $1.50 per share, and 750,000 are priced at $2.00 per share. It is the Company’s intention to settle the Smallwood SARs in cash if the stock price exceeds the $1.50 and $2.00 per share price prior to the expiration date. The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense. At March 31, 2024, the Smallwood SARs had a fair value of $373,918; the increase in fair value in the amount $118,898 during the three months ended March 31, 2024 was charged to non-cash compensation. See note 13.

 

 

The Smallwood SARs were valued using the Black-Scholes valuation model utilizing the following variables:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 

Volatility

    86.58 %     45.0-53.3 %

Dividends

  $ -     $ -  

Risk-free interest rates

    4.59 %     3.67-4.87 %

Term (years)

    2.75       2.63-2.51  

 

Options

 

The following table summarizes the options outstanding at March 31, 2024 and the related prices for the options to purchase shares of the Company’s common stock issued by the Company:

 

                       

Weighted

           

Weighted

 
               

Weighted

   

average

           

average

 
               

average

   

exercise

           

exercise

 

Range of

   

Number of

   

Remaining

   

price of

   

Number of

   

price of

 

exercise

   

options

   

contractual

   

outstanding

   

options

   

exercisable

 

Prices

   

Outstanding

   

life (years)

   

Options

   

Exercisable

   

Options

 
$ 0.41       125,000       0.07     $ 0.41       125,000     $ 0.41  
$ 0.50       125,000       0.07     $ 0.50       125,000     $ 0.50  
$ 0.60       50,000       1.75     $ 0.60       43,750     $ 0.60  
$ 1.00       50,000       1.75     $ 1.00       43,750     $ 1.00  
$ 1.25       130,000       2.25     $ 1.25       -     $ -  
$ 1.75       130,000       2.25     $ 1.75       -     $ -  
          610,000       1.27     $ 0.96       350,000     $ 0.55  

 

Transactions involving stock options are summarized as follows:

 

   

Number of Shares

   

Weighted Average

Exercise Price

 

Options outstanding at December 31, 2023

    350,000     $ 0.55  
                 

Granted

    260,000     $ 1.50  

Exercised

    -     $ -  

Cancelled / Expired

    -     $ -  
                 

Options outstanding at March 31, 2024 (unaudited)

    610,000     $ 0.96  

Options exercisable at March 31, 2024 (unaudited)

    350,000     $ 0.55  

 

Aggregate intrinsic value of options outstanding and exercisable at March 31, 2024 was $156,075. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the fiscal period, which was $1.00 at March 31, 2024, and the exercise price multiplied by the number of options outstanding.

 

During the three months ended March 31, 2024 and 2023, the Company charged the amount of $2,034 and $0, respectively, to operations for the vesting of stock options.

 

 

16. RELATED PARTY TRANSACTIONS

 

Payments to Prior Executive Officers under Separation Agreements

 

During the three months ended March 31, 2024, the Company made the following payments to previous Executive Officers in connection with separation agreements (see note 12):

 

The Company paid cash in the amount of $83,333 to Mr. Klepfish, its prior CEO.

 

The Company made Cobra payments on behalf of Mr. Weirnasz, its prior Director of Strategic Acquisitions and previous board member, in the amount of $967.

 

The Company made cash payments to Mr. Tang, its prior CFO, in the amount of $41,125, and made Cobra payments on behalf of Mr. Tang in the amount of $2,885.

 

17. MAJOR CUSTOMERS

 

The Company’s largest customer, U.S. Foods, Inc. and its affiliates, accounted for approximately 49% and 47% of total sales in the three months ended March 31, 2024 and 2023, respectively. In addition, Gate Gourmet, the leading global provider of airline catering solutions and provisioning services for airlines, in partnership with igourmet, represented 17% and 16% of total sales for the three months ended March 31, 2024 and 2023, respectively.

 

18. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

On September 16, 2019, an action (the “PA Action”) was filed in the Court of Common Pleas of Philadelphia County, Trial Division, against, among others, the Company and its wholly-owned subsidiaries, igourmet and Food Innovations, Inc. On January 5, 2024, all parties to the PA Action came to an agreement at Mediation on the material terms of settlement and on January 22, 2024, a settlement was agreed upon in an action filed in the Court of Common Pleas of Philadelphia County, Trial Division against, among others, the Company and its wholly owned subsidiaries, igourmet and Food Innovations, Inc. On Monday, January 29, 2024, the Company received a settlement and release agreement from certain plaintiffs in the PA Action. The Company and its subsidiaries resolved all liabilities within the coverages of their insurance carriers.

 

From time to time, the Company has become and may become involved in certain lawsuits and legal proceedings which arise in the ordinary course of business, or as the result of current or previous investments, or current or previous subsidiaries, or current or previous employees, or current or previous directors, or as a result of acquisitions and dispositions or other corporate activities. The Company intends to vigorously defend its positions. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our financial position or our business and the outcome of these matters cannot be ultimately predicted.

 

19. SUBSEQUENT EVENTS

 

Share Incentive Plan Performance Goal Achieved

 

On April 17, 2024, the Company’s stock price achieved the first price target of $0.87 under the COO Stock Plan and the Company became obligated to issue a total of 196,627 shares to its COO.

 

 

ITEM 2 - MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

FORWARD LOOKING STATEMENTS

 

The following discussion should be read in conjunction with the consolidated financial statements and the related notes thereto, as well as all other related notes, and financial and operational references, appearing elsewhere in this document.

 

Certain information contained in this discussion and elsewhere in this report may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and is subject to the safe harbor created by that act. The safe harbor created by the Private Securities Litigation Reform Act will not apply to certain “forward looking statements” because we issued “penny stock” (as defined in Section 3(a)(51) of the Securities Exchange Act of 1934 and Rule 3(a)(51-1) under the Exchange Act) during the three year period preceding the date(s) on which those forward looking statements were first made, except to the extent otherwise specifically provided by rule, regulation or order of the Securities and Exchange Commission. We caution readers that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking statements which may be deemed to have been made in this Report or which are otherwise made by or on our behalf. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “expect”, “believe”, “explore”, “consider”, “anticipate”, “intend”, “could”, “estimate”, “plan”, “propose” or “continue” or the negative variations of those words or comparable terminology are intended to identify forward-looking statements. Factors that may affect our results include, but are not limited to, the risks and uncertainties associated with:

 

Our ability to raise capital necessary to sustain our anticipated operations and implement our business plan,

 

 

Our ability to implement our business plan,

 

 

Our ability to generate sufficient cash to pay our lenders and other creditors,

 

 

Our dependence on one major customer,

 

 

Our ability to employ and retain qualified management and employees,

 

 

Our dependence on the efforts and abilities of our current employees and executive officers,

 

 

Changes in government regulations that are applicable to our current or anticipated business,

 

 

Changes in the demand for our services and different food trends,

 

 

The degree and nature of our competition,

 

 

The lack of diversification of our business plan,

 

 

The general volatility of the capital markets and the establishment of a market for our shares, and

 

 

Disruption in the economic and financial conditions primarily from the impact of past terrorist attacks in the United States, threats of future attacks, police and military activities overseas and other disruptive worldwide political and economic events, health pandemics, rising inflation and energy costs, and environmental weather conditions.

 

We are also subject to other risks detailed from time to time in our other filings with the SEC and elsewhere in this report. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

 

 

Critical Accounting Policy and Estimates

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates include certain assumptions related to, among others, doubtful accounts receivable, valuation of stock-based services, operating right of use assets and liabilities, and income taxes. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, income taxes, intangible assets, contingent liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

 

Provision for Doubtful Accounts Receivable

 

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts pursuant to the guidance of Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326) as codified in Accounts Standards Codification (ASC) 326, Financial Instruments – Credit Losses. Under ASC 326, the Company utilizes a current and expected credit loss (CECL) impairment model. ASU 2016-13 became effective for us on January 1, 2023. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. Accounts receivable are presented net of an allowance for doubtful accounts of $69,359 and $46,477 at March 31, 2024 and December 31, 2023, respectively.

 

Fair Value of Financial Instruments

 

The Company measures its financial assets and liabilities in accordance with accounting principles generally accepted in the United States of America. The estimated fair values approximate their carrying value because of the short-term maturity of these instruments or the stated interest rates are indicative of market interest rates. These fair values have historically varied due to the market price of the Company’s stock at the date of valuation.

 

Income Taxes

 

The Company uses the liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. The measurement of deferred tax assets and liabilities is based on provisions of applicable tax law. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance based on the amount of tax benefits that, based on available evidence, is not expected to be realized.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets (“ROU assets”) and short-term and long-term lease liabilities are included on the face of the condensed consolidated balance sheet. Finance lease ROU assets are presented within other assets, and finance lease liabilities are presented within accrued liabilities.

 

ROU assets represent the right of use to an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For lease agreements with terms less than 12 months, the Company has elected the short-term lease measurement and recognition exemption, and it recognizes such lease payments on a straight-line basis over the lease term.

 

 

Our Business Activities

 

Innovative Food Holdings (IVFH) builds dynamic scalable businesses by selling specialty foods that are difficult to find through traditional channels. Our expertise is forging close relationships with the producers, growers, makers and distributors of specialty products, then carefully selecting our suppliers based on their quality, uniqueness and reliability.

 

The IVFH team is adept at evaluating and certifying the food safety and supply chain capabilities of small batch producers who don’t typically sell through broad-based sales channels. We seek out the freshest, most unique, origin-specific gourmet cheese, meat, produce, and premium ingredients available, and distribute them directly from our robust network of vendors and warehouses within 24 – 72 hours of an order being placed. We also source, package, and brand a meaningful segment of these products ourselves, enabling us to better control the assortment, offer more flexibility and variety to our customers, and capture additional margin.

 

We leverage this unique, premium assortment to serve the needs of Professional Chefs in settings such as restaurants, hotels, country clubs, national chain accounts, casinos, hospitals and catering houses. We provide these premium customers with products that can’t typically be found through their broadline distributor’s warehouse assortment. We distribute these products directly to Professional Chefs in Chicago through our subsidiary, Artisan Specialty Foods, Inc., and nationally through our e-commerce businesses on Amazon.com and our own website. We also drop ship specialty foods to Professional Chefs nationally through the websites of broadline distributors, such as US Foods, Inc. Between this variety of sales channels, IVFH is able to serve our Professional Chef customers wherever they are located.

 

We have made the strategic decision to sell our 200K square foot facility in Mountain Top, Pennsylvania and consolidate our warehouse activities into our 28K square foot facility in the greater Chicago area. We have the capabilities to pack and ship frozen, refrigerated, and ambient products, enabling us to sell a broad range of specialty foods. We also have GFSI/SQF certifications, allowing compatibility with the highest standards of food handling supply chains in the world, and the quality and food safety that our premium customers expect from us. These warehouses have the ability to ship packages and pallets of all sizes through overnight shipping. We also leverage our own fleet of trucks to deliver directly to our Professional Chef customers within our reach.

 

Our proprietary technology platform underpins our entire business, driving transparency and efficiency up and down the supply chain. Orders flow in real time, whether to our warehouses or to our vendor partners, to allow for fast handling and fulfillment. Our picking is enabled by efficient scan-based, handheld devices, ensuring order and inventory accuracy. Our warehouse management software optimizes pick routes for common items and order types, recommends a box size, and calculates the appropriate amount of packaging and ice required based on forecasted temperatures along the delivery route.

 

We have built a team consisting of passionate, committed, and food-obsessed people: our average tenure (outside of seasonal workers) across the company is over five years. Our merchandising team has deep connections within the specialty food space around the globe. Our Chef Advisors, as ex-chefs themselves, go beyond customer service to offer our Professional Chefs customer support, menu ideas, and preparation guidance.

 

RESULTS OF OPERATIONS

 

This discussion may contain forward looking statements that involve risks and uncertainties. Our future results could differ materially from the forward looking statements discussed in this report. This discussion should be read in conjunction with our consolidated financial statements, the notes thereto and other financial information included elsewhere in the report.

 

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

 

Revenue

 

Revenue decreased by $1.0 million or approximately 5.7% to $15.7 million for the three months ended March 31, 2024 from $16.7 million in the prior year. These revenue declines were driven primarily by our consumer eCommerce business sales declining by 41.7%, as we began the ramp-down of the business. In fact, this shift of focus to our Specialty Foodservice business has already begun to make an impact.  After several quarters of decline our Specialty Foodservice business sales grew by 1.4%. While we expect this Specialty Foodservice revenue to generate positive growth for the year, Q2 will likely be our toughest quarter.   As we’ve said previously, the B2B sales cycle is long, but we remain optimistic in how our sales efforts are progressing.  Shortly after the close of the first quarter, we announced the signing of a contract with a new customer, Cheney Brothers, and conversations with other large potential customers continue. Within our Specialty Foodservice business, we also continue to build out our sourcing efforts, significantly ramping up the pace of our vendor and item onboarding, which we also expect to begin to contribute to revenue growth in the back half of 2024. 

 

 

Any changes in the food distribution and specialty foods operating landscape that materially hinders our current ability and/or cost to deliver our products to our customers could potentially cause a material impact on our net revenue and gross margin and, therefore, our profitability and cash flows could be adversely affected.

 

We also saw a decrease in our logistics business (from $248,569 in the three months ended March 31, 2023 to $208,211 in the three months ended March 31, 2024) as our existing customers experienced softness in demand and subsequently less volume throughput for our logistics services. Though small, we continue to seek new opportunities to leverage our logistics services in order to better leverage existing fixed assets.

 

Currently, a small portion of our revenues comes from imported products or international sales. Our current sales from such markets may be hampered and negatively impacted by any economic tariffs that may be imposed in the United States or in foreign countries.

 

See “Transactions with Major Customers” and the Securities and Exchange Commission’s (“SEC”) mandated FR-60 disclosures following the “Liquidity and Capital Resources” section for a further discussion of the significant customer concentrations, loss of significant customer, critical accounting policies and estimates, and other factors that could affect future results.

 

Cost of goods sold

 

Our cost of goods sold for the three months ended March 31, 2024 was $11.9 million, a decrease of $1.0 million or approximately 7.8% compared to cost of goods sold of $12.9 million for the three months ended March 31, 2023. Cost of goods sold was made up of the following expenses for the three months ended March 31, 2024: cost of goods in the amount of $9.1 million ; and shipping, delivery, handling, and purchase allowance expenses in the amount of $2.8 million. Gross margins as a percentage of sales increased during the current period to 24.4% compared to 22.6% during the comparable period, an improvement of 174 basis points, as we continued implementing our strategy to improve cost controls, better manage pricing, and focus more on product mix.  Importantly, the improvement was driven by an improvement in gross margins in the Specialty Foodservice business.  The enhancement in our financial performance was significantly influenced by the increased gross margins within our Specialty Foodservice sector. Additionally, our deliberate shift away from a pricier shipping supplier served to further elevate our margin levels.

 

Selling, general, and administrative expenses

 

Selling, general, and administrative expenses (“SG&A”) decreased by $0.4 million or 9.7% to $4.0million during the three months ended March 31, 2024 compared to $4.4 million for the three months ended March 31, 2023. The decrease in selling, general, and administrative expenses was primarily due to a decrease in legal and professional fees of $0.2 million, a decrease in advertising of $0.2 million, and a decrease in payroll and related costs of $0.1 million.  These decreases were partially offset by an increase in real estate commissions of $0.1 million related to the sale of the Race Track Road Facility. Selling, general, and administrative expenses as a percentage of sales increased from 26.7% of sales during the three months ended March 31, 2023 to 25.5% of sales during the current quarter.

 

Separation costs – executive officers

 

During the three months ended March 31, 2023, the Company entered into a separation agreement with its Prior CEO and current board member with a total cost of $1,819,199 consisting of $1,251,199 in cash payments, $1,199 of Cobra health insurance payments, and stock grants with a value of $568,000. Also, during the three months ended March 31, 2023, the Company entered into a separation agreement with its prior Director of Strategic Acquisitions and board member consisting of cash payments of $100,000 and $26,451 of Cobra health insurance payments. The aggregate separation costs charged to operations during the three months ended March 31, 2023 was $1,945,650; there were no such costs during the current period.

 

Interest expense, net

 

Interest expense, net of interest income, increased by $42,729 or approximately 24.7% to $215,450 during the three months ended March 31, 2024, compared to $172,721 during the three months ended March 31, 2023. The increase was due to an increase in interest accrued or paid on the Company’s commercial loans and notes payable in the amount of $54,367 due to higher interest rates and higher balances under the MapleMark term loans, backed by the USDA. Interest expense also increased due to an increase in the amortization of prepaid loan fees in the amount of $1,283. This increase was partially offset by an increase in interest income in the amount of $12,921.

 

 

Gain on sale of assets

 

During the three months ended March 31, 2024, the Company sold its property located in Bonita Springs, Florida for a gain in the amount of $1,807,516. There was no comparable transaction in the prior period.

 

Gain on sale of subsidiary

 

During the three months ended March 31, 2024, the Company sold its subsidiary Haley Group, Inc.; consideration for the sale was the return to the Company of 21,126 shares of the Company’s common stock with a market value at the time of the sale of $21,126. The Company recorded a gain on the sale of Haley in the amount of $21,126. There was no comparable transaction in the prior period.

 

Other leasing income

 

During the three months ended March 31, 2024 and March 31, 2023, the Company recognized income in the amount of $1,900 in connection with the lease of space in our Mountaintop warehouse facility.

 

Net income (loss) from continuing operations

 

For the reasons above, the Company had net income from continuing operations for the three months ended March 31, 2024 of $1.4 million  compared to a net loss from continuing operations of $(2.8) million during the three months ended March 31, 2023. The net income from continuing operations for the three months ended March 31, 2024 includes a net total of $354,524 in non-cash charges: non-cash compensation in the amount of $220,099, depreciation and amortization expense of $110,260, provision for doubtful accounts of $22,882, and amortization of the discount on notes payable term loans of $1,283. The net loss from continuing operations for the three months ended March 31, 2023 includes a total of $328,101 in non-cash charges, including non-cash compensation in the amount of $178,048, depreciation and amortization expense of $145,387, and provision for doubtful accounts of $4,666.

 

Net loss from discontinued operations

 

For the three months ended March 31, 2024, the Company had a net loss from discontinued operations in the amount of $10,105, a decrease in the amount of $31,946 or approximately 76% compared to a net loss from discontinue operations in the amount of $42,051 for the three months ended March 31, 2023.

 

Liquidity and Capital Resources at March 31, 2024

 

As of March 31, 2024, the Company had current assets of $17,533,707, consisting of cash and cash equivalents of $4,272,243, trade accounts receivable, net, of $4,109,274, inventory of $2,840,682, other current assets of $348,926, assets held for sale of $5,941,933, and current assets – discontinued operations of $20,649. Also at March 31, 2024, the Company had current liabilities of $5,482,266, consisting of trade payables and accrued liabilities of $3,111,671, current portion of accrued separation costs – related parties of $418,635, accrued interest of $93,829, deferred revenue of $1,227,936, liability for stock appreciation rights of $373,918, current portion of notes payable of $100,237, current portion of operating lease liability of $17,422, current portion of financing lease liability of $136,096, and current liabilities - discontinued operations of $2,522.

 

During the three months ended March 31, 2024, the Company had cash used in operating activities of $3,157,213. Cash flow used in operations consisted of the Company’s consolidated net income of $1,425,874 less gain on disposition of assets of $1,807,516 and gain on sale of subsidiary of $21,126, plus non-cash charges for depreciation and amortization of $110,260, increase in value of stock appreciation rights of $118,898, stock-based compensation in the amount of $103,325, provision for doubtful accounts of $22,882, amortization of right-of-use assets of $4,175, and amortization of discount on notes payable of $1,283. The Company’s cash position also decreased by $3,115,178 as a result of changes in the components of current assets and current liabilities, primarily the result of a net paydown of $3,114,335 in accounts payable and accrued liabilities. Excluding $128,610 in payments associated with the separation and hiring of key officers referenced earlier, the Company would have recorded cash used in operating activities of $3,028,603 for the three months ended March 31, 2024, an improvement of $128,608 compared to the three months ended March 31, 2023.

 

The Company had cash provided by investing activities of $2,099,779 for the three months ended March 31, 2024, which consisted of cash received from the sale of our Bonita Springs property in the amount of $2,101,185 net of the payoff of the related secured loan in the amount of $353,815 including accrued interest. The Company also purchased property and equipment in the amount of $1,406 during the period.

 

 

The Company had cash used in financing activities of $72,685 for the three months ended March 31, 2024, which consisted of payments on notes payable and financing lease in the amount of $22,708 and $49,977, respectively.

 

At March 31, 2024, we had positive net working capital in the amount of $12,051,441 compared to net working capital of $5,000,156 at the December 31, 2023, an improvement of $7,051,285. The Company reported a profit from continuing operations in the amount of $1,435,979 for the three months ended March 31, 2024 compared to a loss from continuing operations of $2,786,715 during the comparable period of the prior year. In addition, the Company continues to maintain the untapped $3 million revolver with MapleMark. Due to the Company’s improved operations performance along with its restructured balance sheet, we believe that any issues regarding our near-term liquidity have been resolved.

 

During 2024, management is focused on continuing the Stabilization phase of its three phase plan, focusing on the fundamentals of running a cash flow positive business, serving Professional Chefs, including a focus on improving margins. Management expects to continue to expand the Professional Chefs business by entering additional specialty foods markets, serving new customers, and launching new products. On the Home Gourmet business, management has kicked off the marketing of the business for divestiture, and in the meantime has eliminated all marketing spend, reduced headcount, and eliminated unproductive inventory.

 

No assurances can be given that any of these plans will come to fruition or that if implemented they will necessarily yield positive results.

 

Transactions with Major Customers

 

Transactions with a major customer and related economic dependence information is set forth below and following our discussion of Liquidity and Capital Resources.

 

The Company’s largest customer, U.S. Foods, Inc. and its affiliates, accounted for approximately 49% and 47% of total sales in the three months ended March 31, 2024 and 2023, respectively. In addition, Gate Gourmet, the leading global provider of airline catering solutions and provisioning services for airlines, in partnership with igourmet, represented 16% of total sales for the three months ended March 31, 2024 and 2023.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

 

Inflation

 

In the opinion of management, inflation has had a material effect on the Company’s financial condition and results of its operations. The Company has seen the impact of inflation across its costs for fuel, shipping, cost of goods, and marketing. Balancing the management of these increases with the willingness of our customers to pay higher prices will continue to be a key focus for the Company this year. However, no assurance can be given that we will be successful and inflationary pressure on our profits will likely continue through 2024.

 

RISK FACTORS

 

The Company’s business and success is subject to numerous risk factors as detailed in its Annual Report on Form 10-K for the year ended December 31, 2023 and other of its Current Reports on Form 8-K, all of which reports are available at no cost at www.sec.gov.

 

ITEM 4 - CONTROLS AND PROCEDURES

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit pursuant to the requirements of the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, among other things, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure.

 

(a) Evaluation of disclosure controls and procedures

 

Our Principal Executive Officer and Principal Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined as defined in Rule 13a-15(f) and 15d-(f) under the Exchange Act.) as of the end of the period covered by this Quarterly Report, have determined that our controls and procedures are effective at March 31, 2024 at the reasonable assurance level. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework (2013).

 

(b) Changes in internal control over financial reporting

 

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rules 13a-15(d) and 15d-15 that occurred during the period covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On September 16, 2019, an action (the “PA Action”) was filed in the Court of Common Pleas of Philadelphia County, Trial Division, against, among others, the Company and its wholly-owned subsidiaries, igourmet and Food Innovations, Inc. On January 5, 2024, all parties to the PA Action came to an agreement at Mediation on the material terms of settlement and on January 22, 2024, a settlement was agreed upon in an action filed in the Court of Common Pleas of Philadelphia County, Trial Division against, among others, the Company and its wholly owned subsidiaries, igourmet and Food Innovations, Inc. On Monday, January 29, 2024, the Company received a settlement and release agreement from certain plaintiffs in the PA Action. The Company and its subsidiaries resolved all liabilities within the coverages of their insurance carriers.

 

From time to time, the Company has become and may become involved in certain lawsuits and legal proceedings which arise in the ordinary course of business, or as the result of current or previous investments, or current or previous subsidiaries, or current or previous employees, or current or previous directors, or as a result of acquisitions and dispositions or other corporate activities. The Company intends to vigorously defend its positions. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our financial position or our business, and the outcome of these matters cannot be ultimately predicted.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None

 

 

Item 6. Exhibits

 

3.1

Articles of Incorporation (incorporated by reference to exhibit 3.1 of the Company’s annual report on Form 10-KSB for the year ended December 31, 2004 filed with the Securities and Exchange Commission on September 28, 2005).

 

 

3.2

Amended Bylaws of the Company (incorporated by reference to exhibit 3.2 of the Company’s annual report Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission on March 16, 2011).

 

 

3.2.1

Amended Bylaws of the Company (incorporated by reference to exhibit 3.1 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on March 13, 2023).

 

 

10.1

Executive Employment Agreement dated February 3, 2023 between the Registrant and Robert William Bennett (incorporated by reference to exhibit 10.1 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on February 7, 2023)

 

 

10.2

Agreement and General Release dated February 3, 2023 between the Registrant and Samuel Klepfish (incorporated by reference to exhibit 10.2 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on February 7, 2023)

 

 

10.3

Side Letter dated February dated February 3, 2023 between the Registrant and Samuel Klepfish (incorporated by reference to exhibit 10.3 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on February 7, 2023)

 

 

31.1

Section 302 Certification

 

 

31.2

Section 302 Certification

 

 

32.1

Section 906 Certification

 

 

32.2

Section 906 Certification

 

 

101.INS

Inline XBRL Instance Document

 

 

101.SCH

Inline XBRL Taxonomy Extension Schema

 

 

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

 

 

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

 

 

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

 

 

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

 

 

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

SIGNATURE

 

TITLE

 

DATE

 

 

 

 

 

/s/ Robert William Bennett

 

Chief Executive Officer and Director

 

May 14, 2024

Robert William Bennett

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Gary Schubert

 

Chief Financial Officer

 

May 14, 2024

Gary Schubert

 

 

 

 

 

35
NONE false --12-31 Q1 0000312257 0000312257 2024-01-01 2024-03-31 0000312257 2024-05-13 0000312257 2024-03-31 0000312257 2023-12-31 0000312257 2023-01-01 2023-03-31 0000312257 us-gaap:CommonStockMember 2022-12-31 0000312257 ivfh:CommonStockToBeIssuedMember 2022-12-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000312257 us-gaap:TreasuryStockCommonMember 2022-12-31 0000312257 us-gaap:RetainedEarningsMember 2022-12-31 0000312257 2022-12-31 0000312257 ivfh:CommonStockToBeIssuedMember 2023-01-01 2023-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000312257 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000312257 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000312257 us-gaap:CommonStockMember 2023-03-31 0000312257 ivfh:CommonStockToBeIssuedMember 2023-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000312257 us-gaap:TreasuryStockCommonMember 2023-03-31 0000312257 us-gaap:RetainedEarningsMember 2023-03-31 0000312257 2023-03-31 0000312257 us-gaap:CommonStockMember 2023-12-31 0000312257 ivfh:CommonStockToBeIssuedMember 2023-12-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000312257 us-gaap:TreasuryStockCommonMember 2023-12-31 0000312257 us-gaap:RetainedEarningsMember 2023-12-31 0000312257 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000312257 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000312257 us-gaap:CommonStockMember 2024-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000312257 us-gaap:TreasuryStockCommonMember 2024-03-31 0000312257 us-gaap:RetainedEarningsMember 2024-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000312257 us-gaap:RestrictedStockMember 2024-03-31 0000312257 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-01-01 2024-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-01-01 2024-03-31 0000312257 srt:ChiefExecutiveOfficerMember 2024-01-01 2024-03-31 0000312257 us-gaap:RestrictedStockMember 2023-03-31 0000312257 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-03-31 0000312257 srt:ChiefExecutiveOfficerMember 2023-01-01 2023-03-31 0000312257 ivfh:SpecialtyFoodServicesMember 2024-01-01 2024-03-31 0000312257 ivfh:SpecialtyFoodServicesMember 2023-01-01 2023-03-31 0000312257 ivfh:EcommerceMember 2024-01-01 2024-03-31 0000312257 ivfh:EcommerceMember 2023-01-01 2023-03-31 0000312257 ivfh:WarehouseAndLogisticServicesMember 2024-01-01 2024-03-31 0000312257 ivfh:WarehouseAndLogisticServicesMember 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt041Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt041Member 2024-03-31 0000312257 ivfh:OptionsAt050Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt050Member 2024-03-31 0000312257 ivfh:OptionsAt060Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt060Member 2024-03-31 0000312257 ivfh:OptionsAt100Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt100Member 2024-03-31 0000312257 ivfh:OptionsAt125Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt125Member 2024-03-31 0000312257 ivfh:OptionsAt175Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt175Member 2024-03-31 0000312257 ivfh:OptionsAt041Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt041Member 2023-03-31 0000312257 ivfh:OptionsAt050Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt050Member 2023-03-31 0000312257 ivfh:OptionsAt060Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt060Member 2023-03-31 0000312257 ivfh:OptionsAt062Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt062Member 2023-03-31 0000312257 ivfh:OptionsAt085Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt085Member 2023-03-31 0000312257 ivfh:OptionsAt100Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt100Member 2023-03-31 0000312257 ivfh:OptionsAt120Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt120Member 2023-03-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2024-03-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2023-12-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2024-01-01 2024-03-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-03-31 0000312257 ivfh:HaleyFoodGroupIncMember 2024-02-26 0000312257 ivfh:HaleyFoodGroupIncMember 2024-02-26 2024-02-26 0000312257 2024-02-26 2024-02-26 0000312257 2024-02-26 0000312257 us-gaap:LandMember 2024-03-31 0000312257 us-gaap:LandMember 2023-12-31 0000312257 us-gaap:BuildingMember 2024-03-31 0000312257 us-gaap:BuildingMember 2023-12-31 0000312257 us-gaap:ComputerEquipmentMember 2024-03-31 0000312257 us-gaap:ComputerEquipmentMember 2023-12-31 0000312257 us-gaap:EquipmentMember 2024-03-31 0000312257 us-gaap:EquipmentMember 2023-12-31 0000312257 us-gaap:FurnitureAndFixturesMember 2024-03-31 0000312257 us-gaap:FurnitureAndFixturesMember 2023-12-31 0000312257 us-gaap:VehiclesMember 2024-03-31 0000312257 us-gaap:VehiclesMember 2023-12-31 0000312257 ivfh:RaceTrackRoadPropertyMember 2024-02-14 2024-02-14 0000312257 us-gaap:LandMember 2024-03-31 0000312257 us-gaap:LandMember 2023-12-31 0000312257 us-gaap:BuildingMember 2024-03-31 0000312257 us-gaap:BuildingMember 2023-12-31 0000312257 us-gaap:FurnitureAndFixturesMember 2024-03-31 0000312257 us-gaap:FurnitureAndFixturesMember 2023-12-31 0000312257 srt:MinimumMember 2024-03-31 0000312257 srt:MaximumMember 2024-03-31 0000312257 us-gaap:OfficeEquipmentMember 2024-03-31 0000312257 us-gaap:OfficeEquipmentMember 2023-12-31 0000312257 ivfh:FinanceLease6Member 2024-03-31 0000312257 ivfh:FinanceLease6Member 2023-12-31 0000312257 ivfh:FinanceLease6Member 2021-07-12 0000312257 ivfh:FinanceLease6Member 2021-07-12 2021-07-12 0000312257 ivfh:FinanceLease6Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease5Member 2024-03-31 0000312257 ivfh:FinanceLease5Member 2023-12-31 0000312257 ivfh:FinanceLease5Member 2021-07-15 0000312257 ivfh:FinanceLease5Member 2021-07-15 2021-07-15 0000312257 ivfh:FinanceLease5Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease1Member 2024-03-31 0000312257 ivfh:FinanceLease1Member 2023-12-31 0000312257 ivfh:FinanceLease1Member 2020-10-14 2020-10-14 0000312257 ivfh:FinanceLease1Member 2020-10-14 0000312257 ivfh:FinanceLease1Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease2Member 2024-03-31 0000312257 ivfh:FinanceLease2Member 2023-12-31 0000312257 ivfh:FinanceLease2Member 2020-03-31 2020-03-31 0000312257 ivfh:FinanceLease2Member 2020-03-31 0000312257 ivfh:FinanceLease2Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease3Member 2024-03-31 0000312257 ivfh:FinanceLease3Member 2023-12-31 0000312257 ivfh:FinanceLease3Member 2018-11-05 2018-11-05 0000312257 ivfh:FinanceLease3Member 2018-11-05 0000312257 ivfh:FinanceLease3Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease4Member 2024-03-31 0000312257 ivfh:FinanceLease4Member 2023-12-31 0000312257 ivfh:FinanceLease4Member 2019-08-23 0000312257 ivfh:FinanceLease4Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease4Member 2019-08-23 2019-08-23 0000312257 ivfh:FinanceLease7Member 2024-03-31 0000312257 ivfh:FinanceLease7Member 2023-12-31 0000312257 ivfh:FinanceLease7Member 2022-02-04 0000312257 ivfh:FinanceLease7Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease7Member 2022-02-04 2022-02-04 0000312257 ivfh:ArtisanMember 2024-03-31 0000312257 us-gaap:TradeNamesMember 2024-03-31 0000312257 us-gaap:TradeNamesMember 2023-12-31 0000312257 2023-02-03 2023-02-03 0000312257 ivfh:FormerCEOAndDirectorMember 2023-02-03 0000312257 ivfh:FormerCEOAndDirectorMember 2023-02-03 2023-02-03 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2023-02-03 2023-02-03 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2023-02-03 2023-02-03 0000312257 ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:PaymentDueMarch152023Member ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:PaymentDueOnApril152023Member ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2024-01-01 2024-03-31 0000312257 ivfh:RichardTangMember 2024-02-06 2024-02-06 0000312257 ivfh:LegalFeesMember ivfh:RichardTangMember 2024-02-06 2024-02-06 0000312257 ivfh:PaymentDueMarch42024Member ivfh:RichardTangMember 2024-02-06 2024-02-06 0000312257 ivfh:PaymentDueMarch112024Member ivfh:RichardTangMember 2024-03-11 2024-07-01 0000312257 ivfh:MrKlepfishMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:MrWiernaszMember 2024-01-01 2024-03-31 0000312257 ivfh:MrTangMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:MrTangMember 2024-01-01 2024-03-31 0000312257 ivfh:CashPaymentDueMarch62026Member ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:CashPaymentDueMarch62026Member ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:CashPaymentDueMarch62026Member ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:SharesIssuedApril2023Member ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:SharesIssuedApril2023Member ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:SharesIssuedApril2023Member ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-12-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-01-01 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-12-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-03-31 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2023-12-31 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember srt:ChiefFinancialOfficerMember 2023-12-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember srt:ChiefFinancialOfficerMember 2024-01-01 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember srt:ChiefFinancialOfficerMember 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember srt:ChiefFinancialOfficerMember 2023-12-31 0000312257 us-gaap:OtherInsuranceProductLineMember srt:ChiefFinancialOfficerMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember srt:ChiefFinancialOfficerMember 2024-03-31 0000312257 srt:ChiefFinancialOfficerMember 2023-12-31 0000312257 srt:ChiefFinancialOfficerMember 2024-01-01 2024-03-31 0000312257 srt:ChiefFinancialOfficerMember 2024-03-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-05-15 2023-05-15 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-05-15 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-05-16 2023-12-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-12-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2024-01-01 2024-03-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2024-03-31 0000312257 ivfh:MapleMarkTermLoan3Member 2024-03-31 0000312257 ivfh:MapleMarkTermLoan3Member 2023-12-31 0000312257 ivfh:MapleMarkTermLoan3Member 2023-06-13 0000312257 ivfh:MapleMarkTermLoan3Member 2023-01-04 2048-06-13 0000312257 ivfh:MapleMarkTermLoan3Member 2023-06-13 2023-06-13 0000312257 ivfh:MapleMarkTermLoan3Member 2024-01-01 2024-03-31 0000312257 ivfh:MapleMarkTermLoan3Member ivfh:PrincipalMember 2024-01-01 2024-03-31 0000312257 ivfh:MapleMarkTermLoan2Member 2024-03-31 0000312257 ivfh:MapleMarkTermLoan2Member 2023-12-31 0000312257 ivfh:MapleMarkTermLoan2Member 2022-06-06 0000312257 ivfh:MapleMarkTermLoan2Member 2023-06-09 2023-06-09 0000312257 ivfh:MapleMarkTermLoan2Member 2023-01-01 2033-06-01 0000312257 ivfh:MapleMarkTermLoan2Member 2023-06-09 0000312257 ivfh:MapleMarkTermLoan2Member 2022-06-06 2022-06-06 0000312257 ivfh:MapleMarkTermLoan2Member 2022-12-31 0000312257 ivfh:MapleMarkTermLoan2Member 2024-01-01 2024-03-31 0000312257 us-gaap:ConvertibleDebtMember 2024-03-31 0000312257 us-gaap:ConvertibleDebtMember 2023-12-31 0000312257 us-gaap:ConvertibleDebtMember 2024-01-01 2024-03-31 0000312257 ivfh:MrBennettMember 2024-03-31 0000312257 ivfh:PreviousCFOMember 2023-02-28 2023-02-28 0000312257 2023-02-28 2023-02-28 0000312257 ivfh:PreviousCEOMember 2023-01-01 2023-03-31 0000312257 ivfh:OfficersAndDirectorsMember 2023-01-01 2023-03-31 0000312257 srt:MinimumMember us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000312257 srt:MaximumMember us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000312257 2023-11-07 2023-11-07 0000312257 srt:ChiefExecutiveOfficerMember 2023-11-07 2023-11-07 0000312257 ivfh:MrBennettMember 2024-03-19 0000312257 srt:ChiefOperatingOfficerMember 2023-05-15 2023-05-15 0000312257 srt:ChiefOperatingOfficerMember 2024-01-01 2024-03-31 0000312257 srt:ChiefFinancialOfficerMember 2024-01-01 2024-01-01 0000312257 ivfh:SARsPricedAt150Member 2023-05-15 2023-05-15 0000312257 ivfh:SARsPricedAt150Member 2023-05-15 0000312257 ivfh:SARsPricedAt200Member 2023-05-15 2023-05-15 0000312257 ivfh:SARsPricedAt200Member 2023-05-15 0000312257 us-gaap:EmployeeStockOptionMember 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000312257 ivfh:StockPriceTarget060Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget080Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget100Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget120Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget140Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget160Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget180Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget200Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget087Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget116Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget145Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget174Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget203Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget232Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget261Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget290Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget123Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget163Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget204Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget245Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget286Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget327Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget368Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget408Member 2024-01-01 2024-03-31 0000312257 srt:MinimumMember 2023-01-01 2023-12-31 0000312257 srt:MaximumMember 2023-01-01 2023-12-31 0000312257 2023-01-01 2023-12-31 0000312257 srt:MinimumMember us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-31 0000312257 srt:MaximumMember us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt041Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt041Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt050Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt050Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt060Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt060Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt100Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt100Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt125Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt125Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt175Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt175Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember 2023-12-31 0000312257 ivfh:GateGourmetMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000312257 ivfh:GateGourmetMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000312257 us-gaap:PerformanceSharesMember us-gaap:SubsequentEventMember 2024-04-17 2024-04-17 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

 

EXHIBIT 31.1

 

Certifications

 

I, Robert William Bennett, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Innovative Food Holdings, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: May 14, 2024

 

/s/ Robert William Bennett                          

Robert William Bennett, Chief Executive Officer

 

 

 

EXHIBIT 31.2

 

Certifications

 

I, Gary Schubert, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Innovative Food Holdings, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: May 14, 2024

 

/s/ Gary Schubert                                           

Gary Schubert, Chief Financial Officer

 

 

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

CERTIFICATION

 

In connection with the Quarterly Report of Innovative Food Holdings, Inc. and Subsidiaries (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert William Bennett, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

/s/ Robert William Bennett               

Robert William Bennett

Chief Executive Officer and Director

 

May 14, 2024

 

 

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

CERTIFICATION

 

In connection with the Quarterly Report of Innovative Food Holdings, Inc. and Subsidiaries (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gary Schubert, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

/s/ Gary Schubert                               

Gary Schubert

Chief Financial Officer

 

May 14, 2024

 

 
v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 13, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name INNOVATIVE FOOD HOLDINGS, INC.  
Entity Central Index Key 0000312257  
Entity File Number 0-9376  
Entity Tax Identification Number 20-1167761  
Entity Incorporation, State or Country Code FL  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 9696 Bonita Beach Rd.  
Entity Address, Address Line Two Ste. 208  
Entity Address, City or Town Bonita Springs  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 34135  
Entity Phone Fax Numbers [Line Items]    
City Area Code 239  
Local Phone Number 596-0204  
Entity Listings [Line Items]    
Title of 12(b) Security N/A  
No Trading Symbol Flag true  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   49,693,803
v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 4,272,243 $ 5,327,016
Accounts receivable, net 4,109,274 4,307,726
Inventory, net 2,840,682 2,973,134
Other current assets 348,926 287,528
Assets held for sale 5,941,933 649,884
Current assets - discontinued operations 20,649 95,861
Total current assets 17,533,707 13,641,149
Property and equipment, net 974,143 7,000,015
Right of use assets, operating leases, net 24,344 28,519
Right of use assets, finance leases, net 411,488 436,403
Tradenames and other unamortizable intangible assets 217,000 217,000
Total assets 19,160,682 21,323,086
Current liabilities    
Accounts payable and accrued liabilities 3,111,671 6,252,951
Accrued separation costs, related parties, current portion 418,635 463,911
Accrued interest 93,829 95,942
Deferred revenue 1,227,936 1,312,837
Stock appreciation rights liability 373,918 255,020
Notes payable - current portion 100,237 121,041
Lease liability - operating leases, current 17,422 17,131
Lease liability - finance leases, current 136,096 115,738
Current liabilities - discontinued operations 2,522 6,422
Total current liabilities 5,482,266 8,640,993
Note payable, net of discount 8,501,474 8,855,000
Accrued separation costs, related parties, non-current 707,692 791,025
Lease liability - operating leases, non-current 6,922 11,388
Lease liability - finance leases, non-current 148,931 219,266
Total liabilities 14,847,285 18,517,672
Commitments & Contingencies (see note 18) 0 0
Stockholders' equity    
Common stock: $0.0001 par value; 500,000,000 shares authorized; 52,516,974 and 52,538,100 shares issued, and 49,693,803 and 49,714,929 shares outstanding at March 31, 2024 and December 31, 2023, respectively 5,249 5,251
Additional paid-in capital 42,844,922 42,762,811
Treasury stock: 2,623,171 shares outstanding at March 31, 2024 and December 31, 2023 (1,141,370) (1,141,370)
Accumulated deficit (37,395,404) (38,821,278)
Total stockholders' equity 4,313,397 2,805,414
Total liabilities and stockholders' equity $ 19,160,682 $ 21,323,086
v3.24.1.1.u2
Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares outstanding 49,693,803 49,714,929
Common stock, shares issued 52,516,974 52,538,100
Treasury stock, shares 2,623,171 2,623,171
v3.24.1.1.u2
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 15,730,113 $ 16,674,759
Cost of goods sold 11,895,799 12,900,609
Gross margin 3,834,314 3,774,150
Selling, general and administrative expenses 4,013,427 4,444,394
Separation costs - executive officers 0 1,945,650
Total operating expenses 4,013,427 6,390,044
Operating (loss) (179,113) (2,615,894)
Other income (expense):    
Interest expense, net (215,450) (172,721)
Gain on sale of assets 1,807,516 0
Gain on sale of subsidiary 21,126 0
Other leasing income 1,900 1,900
Total other income (expense) 1,615,092 (170,821)
Net income (loss) before taxes 1,435,979 (2,786,715)
Income tax expense 0 0
Net income (loss) from continuing operations 1,435,979 (2,786,715)
Net (loss) from discontinued operations (10,105) (42,051)
Consolidated net income (loss) $ 1,425,874 $ (2,828,766)
Net income (loss) per share from continuing operations - basic (in Dollars per share) $ 0.029 $ (0.06)
Net income (loss) per share from continuing operations - diluted (in Dollars per share) 0.028 (0.06)
Net income (loss) per share from discontinued operations - basic (in Dollars per share) 0 0
Net income (loss) per share from discontinued operations - diluted (in Dollars per share) $ 0 $ 0
Weighted average shares outstanding - basic (in Shares) 49,707,036 48,462,234
Weighted average shares outstanding - diluted (in Shares) 50,603,891 48,462,234
v3.24.1.1.u2
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Common Stock to be issued [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 4,938 $ 150 $ 42,189,471 $ (1,141,370) $ (34,466,126) $ 6,587,063
Balance (in Shares) at Dec. 31, 2022 49,427,297 1,499,940   2,623,171    
Shares issued for compensation   $ 20 45,660     45,680
Shares issued for compensation (in Shares)   207,274        
Shares issued to management and employees, previously accrued $ 87 $ (87)        
Shares issued to management and employees, previously accrued (in Shares) 875,000 (875,000)        
Fair value of shares under compensation plan     20,199     20,199
Common stock issued for services $ 27   112,142     112,142
Common stock issued for services (in Shares) 267,030          
Net loss         (2,828,766) (2,828,766)
Balance at Mar. 31, 2023 $ 5,052 $ 83 42,367,472 $ (1,141,370) (37,294,892) 3,936,345
Balance (in Shares) at Mar. 31, 2023 50,569,327 832,214   2,623,171    
Balance at Dec. 31, 2023 $ 5,251 $ 0 42,762,811 $ (1,141,370) (38,821,278) 2,805,414
Balance (in Shares) at Dec. 31, 2023 52,538,100 0   2,623,171    
Shares returned to treasury from sale of subsidiary $ (2)   (21,124)     (21,126)
Shares returned to treasury from sale of subsidiary (in Shares) (21,126)          
Fair value of shares under compensation plan     103,235     103,235
Net loss         1,425,874 1,425,874
Balance at Mar. 31, 2024 $ 5,249   $ 42,844,922 $ (1,141,370) $ (37,395,404) $ 4,313,397
Balance (in Shares) at Mar. 31, 2024 52,516,974     2,623,171    
v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ 1,425,874 $ (2,828,766)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Gain on disposition of asset (1,807,516) 0
Gain on sale of subsidiary (21,126) 0
Depreciation and amortization 110,260 145,387
Amortization of right of use asset 4,175 16,314
Amortization of discount on notes payable 1,283 0
Stock based compensation 103,235 178,048
Loss on value of stock appreciation rights 118,898 0
Provision for doubtful accounts 22,882 4,666
Changes in assets and liabilities:    
Accounts receivable, net 175,436 135,020
Inventory and other current assets, net 71,054 (51,038)
Accounts payable and accrued liabilities (3,144,335) (2,056,459)
Accrued separation costs - related parties (128,610) 1,600,795
Deferred revenue (84,548) (319,365)
Operating lease liability (4,175) (16,314)
Net cash used in operating activities (3,157,213) (3,191,712)
Cash flows from investing activities:    
Acquisition of property and equipment (1,406) (7,995)
Cash received from disposition of asset, net of loan payoff 2,101,185 0
Net cash from (used in) investing activities 2,099,779 (7,995)
Cash flows from financing activities:    
Principal payments on debt (22,708) (2,757)
Principal payments financing leases (49,977) (46,807)
Net cash (used in) financing activities (72,685) (49,564)
Decrease in cash and cash equivalents (1,130,119) (3,249,271)
Cash and cash equivalents at beginning of period 5,422,335 4,899,398
Cash and cash equivalents at end of period - continuing operations 4,272,243 1,435,561
Cash and cash equivalents at end of period - discontinued operations 19,973 214,566
Cash and cash equivalents at end of period 4,292,216 1,650,127
Interest 228,970 174,410
Taxes 0 0
Non-cash investing and financing activities:    
Reclassify fixed assets as held for sale 5,941,933 0
Principal and accrued interest paid from escrow to Maple Mark Bank $ 353,815 $ 0
v3.24.1.1.u2
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]

1. NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements include those of Innovative Food Holdings, Inc. and all of its wholly-owned subsidiaries (collectively, the “Company”) and have been prepared in accordance with generally accepted accounting principles pursuant to Regulation S-X of the Securities and Exchange Commission and with the instructions to Form 10-Q. Certain information and footnote disclosures normally included in audited consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Accordingly, these interim financial statements should be read in conjunction with the Company’s audited financial statements and related notes as contained in Form 10-K for the year ended December 31, 2023. In the opinion of management, the interim unaudited consolidated financial statements reflect all adjustments, including normal recurring adjustments, necessary for fair presentation of the interim periods presented. The results of the operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full year.

 

Business Activity

 

We provide difficult-to-find specialty foods primarily to both Professional Chefs and Home Gourmets through our relationships with producers, growers, makers and distributors of these products worldwide. The distribution of these products primarily originates from our three unified warehouses and those of our drop ship partners, and is driven by our proprietary technology platform. In addition, we provide value-added services through our team of food specialists and Chef Advisors who offer customer support, menu ideas, and preparation guidance.

 

Restructuring

 

During the fourth quarter of 2023 we made the decision to focus more on our Business to Business (B2B) activities and less on our Direct to Consumer (D2C) products. Our subsidiaries GROW and Oasis were sold effective December 29, 2023; Haley was sold effective February 26, 2024; and the activities of P Innovations will be abandoned. Our remaining D2C business, primarily operated within igourmet and Mouth, will be downsized. See note 2.

 

Discontinued Operations

 

Pursuant to the guidance of ASC 205-20 Presentation of Financial Statements Discontinued Operations, the accounts of our discontinued entities GROW, Oasis, Haley, and P Innovations have been included in “Net loss from discontinued operations” in our consolidated statements of operations until such time as each entity was sold. Additionally, the assets and liabilities of these entities have been presented as discontinued operations in our consolidated balance sheets as of March 31, 2024 and December 31, 2023 until such time as each entity was sold. See Note 2.

 

Reclassifications

 

Certain amounts presented in the financial statements of the prior period have been reclassified to conform with the current period presentation of discontinued operations. See note 2.

 

Use of Estimates

 

The preparation of these unaudited consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, inventory reserves, income taxes, intangible assets, operating and finance right of use assets and liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

 

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash in investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limit. At March 31, 2024 and 2023, trade receivables from the Company’s largest customer amounted to 32% and 23%, respectively, of total trade receivables. During the three months ended March 31, 2024 and 2023, sales from the Company’s largest customer amounted to 49% and 47% of total sales, respectively.

 

The Company maintains cash balances in excess of Federal Deposit Insurance Corporation limits. At March 31, 2024 and December 31, 2023, the total cash in excess of these limits was $931,857 and $988,825, respectively.

 

Accounts Receivable

 

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts pursuant to the guidance of Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326) as codified in Accounts Standards Codification (ASC) 326, Financial Instruments – Credit Losses. Under ASC 326, the Company utilizes a current and expected credit loss (CECL) impairment model. ASU 2016-13 became effective for us on January 1, 2023. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. Accounts receivable are presented net of an allowance for doubtful accounts of $69,359 and $46,477 at March 31, 2024 and December 31, 2023, respectively.

 

Leases

 

The Company accounts for leases in accordance with Financial Accounting Standards Board (“FASB”) ASC 842, “Leases”. The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets (“ROU assets”) and short-term and long-term lease liabilities are included on the face of the consolidated balance sheet. Finance lease ROU assets are presented within other assets, and finance lease liabilities are presented within current and long-term liabilities.

 

ROU assets represent the right of use to an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For lease agreements with terms less than 12 months, the Company has elected the short-term lease measurement and recognition exemption, and it recognizes such lease payments on a straight-line basis over the lease term.

 

Revenue Recognition

 

The Company recognizes revenue upon product delivery. All of our products are shipped either same day or overnight or through longer shipping terms to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues.

 

For revenue from product sales (i.e., specialty foodservice and e-commerce), the Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers”. A five-step analysis must be met as outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

 

Warehouse and logistic services revenue is primarily comprised of inventory management, order fulfilment and warehousing services. Warehouse & logistics services revenues are recognized at the point in time when the services are rendered to the customer.

 

Deferred Revenue

 

Certain customer arrangements in the Company’s business such as gift cards and e-commerce subscription purchases result in deferred revenues when cash payments are received in advance of performance. Gift cards issued by the Company generally have an expiration of five years from date of purchase. The Company records a liability for unredeemed gift cards and advance payments for monthly club memberships as cash is received, and the liability is reduced when the card is redeemed or product delivered.

 

The following table represents the changes in deferred revenue as reported on the Company’s consolidated balance sheets:

 

Balance as of December 31, 2022

  $ 1,558,155  

Cash payments received

    215,346  

Net sales recognized

    (534,711 )

Balance as of March 31, 2023 (unaudited)

  $ 1,238,790  

 

Balance as of December 31, 2023

  $ 1,312,837  

Cash payments received

    4,033,077  

Net sales recognized

    (4,117,978 )

Balance as of March 31, 2024 (unaudited)

  $ 1,227,936  

 

Disaggregation of Revenue

 

The following table represents a disaggregation of revenue for the three months ended March 31, 2024 and 2023:

 

   

Three Months Ended

 
   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Specialty Foodservice

  $ 13,993,565     $ 13,804,785  

E-Commerce

    1,528,337       2,621,405  

Logistics

    208,211       248,569  

Total

  $ 15,730,113     $ 16,674,759  

 

Cost of goods sold

 

We have included in cost of goods sold all costs which are directly related to the generation of revenue. These costs include primarily the cost of food and raw materials, packing and handling, shipping, and delivery costs.

 

We have also included all payroll costs as cost of goods sold in our leasing and logistics services business.

 

Basic and Diluted Earnings Per Share

 

Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully-diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during the period.

 

The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation.

 

Dilutive shares at March 31, 2024:

 

Stock Options

 

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2024:

 

               

Weighted

 
               

average

 
               

Remaining

 

Exercise

   

Number of

   

contractual

 

Price

   

Options

   

life (years)

 
$ 0.41       125,000       0.07  
$ 0.50       125,000       0.07  
$ 0.60       50,000       1.75  
$ 1.00       50,000       1.75  
$ 1.25       130,000       2.25  
$ 1.75       130,000       2.25  
          610,000       1.27  

 

Restricted Stock Awards

 

At March 31, 2024, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. The fair value of these RSUs at the date of the grants will be charged to operations upon vesting. At March 31, 2024, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2024.

 

Stock-based Compensation

 

At March 31, 2024, there were a total of 3,910,534 shares of common stock potentially issuable to the Company’s executive officers pursuant to compensation plans and contingent upon the achievement of certain performance goals; see notes 15 and 16.

 

Dilutive shares at March 31, 2023:

 

Stock Options

 

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2023:

 

               

Weighted

 
               

Average

 
               

Remaining

 

Exercise

   

Number

   

Contractual

 

Price

   

of Options

   

Life (years)

 
$ 0.41       125,000       1.07  
$ 0.50       125,000       1.07  
$ 0.60       50,000       2.75  
$ 0.62       360,000       0.75  
$ 0.85       540,000       0.75  
$ 1.00       50,000       2.75  
$ 1.20       950,000       0.74  
          2,200,000       0.87  

 

Restricted Stock Awards

 

At March 31, 2023, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. At March 31, 2023, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2023.

 

Stock-based Compensation

 

At March 31, 2023, there were a total of 3,538,243 shares of common stock potentially issuable to the Company’s Chief Executive Officer pursuant to his compensation plan and contingent upon the achievement of certain performance goals. see notes 15 and 16.

 

New Accounting Pronouncements

 

Management does not believe that any other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

v3.24.1.1.u2
DISCONTINUED OPERATIONS
3 Months Ended
Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

2. DISCONTINUED OPERATIONS

 

During the fourth quarter of fiscal 2023, in connection with an analysis of the Company’s sales mix and profitability by service offering, management made the strategic decision to focus on the Company’s Business to Business (B2B) service offering and to allocate fewer resources to and in some cases to sell certain of the Company’s subsidiaries involved in our Direct to Consumer (D2C) service offerings. Pursuant to this strategy, on December 29, 2023, the Company completed the sales of its Grow and Oasis subsidiaries, and on February 26, 2024, the Company completed the sale of its Haley subsidiary (see note 3). In addition, the operations of P Innovations has been abandoned.

 

The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 

Current assets - discontinued operations:

 

(unaudited)

         

Cash

  $ 19,973     $ 95,319  

Accounts receivable

    635       501  

Inventory

    41       41  

Other current assets

    -       -  

Total current assets - discontinued operations

  $ 20,649     $ 95,861  
                 

Current liabilities - discontinued operations:

               

Accounts payable and accrued liabilities

  $ -     $ 986  

Accrued payroll and related liabilities

    -       3,267  

Deferred revenue

    2,522       2,169  

Total current liabilities - discontinued operations

  $ 2,522     $ 6,422  

 

The following information presents the major classes of line items constituting the after-tax loss from discontinued operations in the consolidated statements of operations:

 

   

Three Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 

Revenue

  $ 24,856     $ 320,441  

Cost of goods sold

    (2,238 )     (8,080 )

Gross margin

    22,618       312,361  
                 

Selling, general, and administrative expenses

    (32,723 )     (354,692 )
                 

Interest income

    -       280  

Loss from discontinued operations, net of tax

  $ (10,105 )   $ (42,051 )

 

There were no major classes of line items which constituted significant operating and investing cash flow activities in the consolidated statements of cash flows relating to discontinued operations.

v3.24.1.1.u2
SALE OF SUBSIDIARY
3 Months Ended
Mar. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments and Joint Ventures Disclosure [Text Block]

3. SALE OF SUBSIDIARY

 

On February 26, 2024, the Company sold 100% of the equity interests in Haley Food Group, Inc., (“Haley”) for the return of 21,126 shares of the Company’s common stock held by the buyer. The Company Haley had no assets of liabilities at the time of the sale; the Company valued the 21,126 shares of common stock at the market price on the date of the acquisition of $1.00 per sale and recorded a gain in the amount of $21,126 on this transaction.

v3.24.1.1.u2
ACCOUNTS RECEIVABLE
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

4. ACCOUNTS RECEIVABLE

 

At March 31, 2024 and December 31, 2023, accounts receivable consists of:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Accounts receivable from customers

  $ 4,178,633     $ 4,354,203  
Allowance for doubtful accounts     (69,359 )     (46,477 )

Accounts receivable, net

  $ 4,109,274     $ 4,307,726  

 

During the three months ended March 31, 2024 and 2023, the Company charged the amount of $22,882 and $4,666 to provision for credit loss, respectively.

v3.24.1.1.u2
INVENTORY
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]

5. INVENTORY

 

Inventory consists primarily of specialty food products. At March 31, 2024 and December 31, 2023, inventory consisted of the following:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Finished goods inventory

  $ 2,840,682     $ 2,973,134  

Allowance for slow moving & obsolete inventory

    -       -  

Finished goods inventory, net

  $ 2,840,682     $ 2,973,134  
v3.24.1.1.u2
PROPERTY AND EQUIPMENT
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]

6. PROPERTY AND EQUIPMENT

 

A summary of property and equipment at March 31, 2024 and December 31, 2023 is as follows:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Land

  $ 208,140     $ 1,079,512  

Building

    711,409       6,571,496  

Computer and Office Equipment

    599,242       597,834  

Warehouse Equipment

    477,090       477,090  

Furniture and Fixtures

    940,960       940,960  

Vehicles

    58,353       58,353  

Total before accumulated depreciation

    2,995,194       9,725,245  

Less: accumulated depreciation

    (2,021,051 )     (2,725,230 )

Total

  $ 974,143     $ 7,000,015  

 

Depreciation expense for property and equipment amounted to $85,345 and $101,576 for the three months ended March 31, 2024 and 2023, respectively. Depreciation expense for property and equipment is recorded in selling, general & administrating expenses on the Company’s statement of operations. During the three months ended March 31, 2024 and 2023, the Company acquired property and equipment in the amount of $1,406 and $7,995, respectively.

v3.24.1.1.u2
PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE
3 Months Ended
Mar. 31, 2024
Property And Equipment Held For Sale Disclosure Abstract  
Property and Equipment, Held for Sale, Disclosure [Text Block]

7. PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE

 

Assets held for sale include the net book value of property and equipment the Company plans to sell within the next year. Long lived assets that meet the criteria are held for sale and reported at the lower of their carrying value or fair value less estimated cost to sell.

 

As of December 31, 2023, the Company classified the land, building, leasehold improvements, and certain equipment located at 28411 Race Track Road, Bonita Springs, Florida, 34135 (the “Race Track Road Property”) as held for sale. On February 14, 2024, the Company finalized the sale of the Race Track Road Property for cash in the amount of $2,455,000. The Company recorded a gain on the sale in the amount of $1,807,516. Proceeds of the sale in the amount of $353,815 were used to pay the mortgage and accrued interest on the Race Track Road Property. Total expenses related to the sale $165,755, including a commission of $147,300, state taxes of $17,185, and closing fees of $1,270.

 

As of March 31, 2024, the Company classified the land and building located at 220 Oak Hill Road, Mountain Top, Pennsylvania, as held for sale.

 

The net book value of these assets consisted of the following at March 31, 2024 and December 31, 2023:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 
                 

Land

  $ 871,372     $ 177,383  

Building

    5,070,561       431,147  

Furniture, fixtures, and equipment

    -       41,314  

Total

  $ 5,941,933     $ 649,844  
v3.24.1.1.u2
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES
3 Months Ended
Mar. 31, 2024
Disclosure Text Block [Abstract]  
Lessee, Operating Leases [Text Block]

8. RIGHT OF USE (ROU) ASSETS AND LEASE LIABILITIES OPERATING LEASES

 

The Company has operating leases for offices, warehouses, vehicles, and office equipment. The Company’s leases have remaining lease terms of 1 year to 3 years, some of which include options to extend.

 

The Company’s lease expense for the three months ended March 31, 2024 and 2023 was entirely comprised of operating leases and amounted to $8,165 and $18,790, respectively.

 

The Company’s ROU asset amortization for the three months ended March 31, 2024 and 2023 was $4,175 and $16,314, respectively. The difference between the lease expense and the associated ROU asset amortization consists of interest.

 

Right of use assets – operating leases are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Right of use assets, net

  $ 24,344     $ 28,519  

 

Operating lease liabilities are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Lease liability

  $ 24,344     $ 28,519  

Less: current portion

    (17,422 )     (17,131 )

Lease liability, non-current

  $ 6,922     $ 11,388  

 

Maturity analysis under these lease agreements are as follows:

 

For the period ended March 31, 2025

  $ 18,532  

For the period ended March 31, 2026

    7,051  

Total

  $ 25,583  

Less: Present value discount

    (1,239 )

Lease liability

  $ 24,344  
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES
3 Months Ended
Mar. 31, 2024
Disclosure Text Block [Abstract]  
Lessee, Finance Leases [Text Block]

9. RIGHT OF USE ASSETS FINANCING LEASES

 

The Company has financing leases for vehicles and warehouse equipment. Right of use asset – financing leases are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Vehicles

  $ 404,858     $ 404,858  

Warehouse Equipment

    555,416       555,416  

Total before accumulated depreciation

    960,274       960,274  

Less: accumulated depreciation

    (548,786 )     (523,871 )

Total

  $ 411,488     $ 436,403  

 

Depreciation expense related to right of use assets for the three months ended March 31, 2024 and 2023 was $24,915 and $33,480, respectively.

 

Financing lease liabilities are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a forklift dated July 12, 2021 in the original amount of $16,070 payable in thirty-six monthly installments of $489 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $1,431 and $36, respectively.

  $ 1,453     $ 2,884  
                 

Financing lease obligation under a lease agreement for a pallet truck dated July 15, 2021 in the original amount of $5,816 payable in thirty-six monthly installments of $177 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $518 and $13, respectively.

  $ 526     $ 1,044  
                 

Financing lease obligation under a lease agreement for warehouse furniture and equipment truck dated October 14, 2020 in the original amount of $514,173 payable in sixty monthly installments of $9,942 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amount of $19,084 and $2,834, respectively.

  $ 170,712     $ 197,707  

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a truck dated March 31, 2020 in the original amount of $152,548 payable in eighty-four monthly installments of $2,188 including interest at the rate of 5.44%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,552 and $1,012, respectively.

  $ 70,666     $ 76,218  
                 

Financing lease obligation under a lease agreement for a truck dated November 5, 2018 in the original amount of $128,587 payable in seventy monthly installments of $2,326 including interest at the rate of 8.33%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $6,647 and $330, respectively.

    11,388     $ 18,035  
                 

Financing lease obligation under a lease agreement for a truck dated August 23, 2019 in the original amount of $80,413 payable in eighty-four monthly installments of $1,148 including interest at the rate of 5.0%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $3,040 and $404, respectively.

  $ 30,282     $ 33,322  
                 

Financing lease obligation under a lease agreement for a truck dated February 4, 2022 in the original amount of $42,500 payable in twenty-four monthly installments of $1,963 including interest at the rate of 10.1%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,794 and $98, respectively.

  $ -     $ 5,794  
                 

Total

  $ 285,027     $ 335,004  
                 

Current portion

  $ 136,096     $ 115,738  

Long-term maturities

    148,931       219,266  

Total

  $ 285,027     $ 335,004  

 

There was no accrued interest on financing leases at March 31, 2024 and December 31, 2023.

 

Aggregate maturities of lease liabilities:

 

For the twelve months ended March 31,

 

2025

  $ 160,993  

2026

    96,060  

2027

    27,974  

Total

  $ 285,027  
v3.24.1.1.u2
INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block]

10. INTANGIBLE ASSETS

 

The Company acquired certain intangible assets pursuant to the acquisitions of Artisan, Oasis, igourmet, OFB, Haley, and Mouth. These assets include non-compete agreements, customer relationships, trade names, internally developed technology, and goodwill. The Company has also capitalized the development of its website.

 

Other Non-Amortizable Intangible Assets

 

Other non-amortizable intangible assets consist of $217,000 of trade names held by Artisan. The Company followed the guidance of ASC 360 “Property, Plant, and Equipment” (“ASC 360”) in assessing these assets for impairment. ASC 360 states that impairment testing should be completed whenever events or changes in circumstances indicate the asset’s carrying value may not be recoverable. In management’s judgment there are no indications that the carrying value of these trade names may not be recoverable, and it determined that impairment testing was not required.

 

The Company acquired certain intangible assets pursuant to the acquisitions through Artisan. The following is the net book value of these assets:

 

   

March 31, 2024

(unaudited)

 
           

Accumulated

         
   

Gross

   

Amortization

   

Net

 

Trade Names

  $ 217,000     $ -     $ 217,000  

 

   

December 31, 2023

 
           

Accumulated

         
   

Cost

   

Amortization

   

Net

 

Total Trade Names

  $ 217,000     $ -     $ 217,000  

 

Total amortization expense for the three months ended March 31, 2024 and 2023 was $0.

v3.24.1.1.u2
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

11. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable and accrued liabilities at March 31, 2024 and December 31, 2023 are as follows:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Trade payables and accrued liabilities

  $ 2,955,157     $ 6,046,396  

Accrued payroll and commissions

    156,514       206,555  

Total

  $ 3,111,671     $ 6,252,951  
v3.24.1.1.u2
ACCRUED SEPARATION COSTS – RELATED PARTIES
3 Months Ended
Mar. 31, 2024
Compensation Related Costs [Abstract]  
Compensation Related Costs, General [Text Block]

12. ACCRUED SEPARATION COSTS RELATED PARTIES

 

On February 3, 2023, the Company entered into a Severance Note, an Agreement and General Release, and a Side Letter thereto with Sam Klepfish (the “SK Agreements”), its prior CEO and a current board member. The SK Agreements provide, among other things, for Mr. Kelpfish’s resignation from all positions with the Company and its subsidiaries on February 28, 2023, except that Mr. Klepfish will remain a director and member of the board of the Company, confidentiality and non-disparagement conditions, nomination of Mr. Klepfish for future election to the board of directors at least through the 2024 general meeting of shareholders based on certain minimum stock ownership and Board Observer rights when Mr. Klepfish is no longer a director but maintains certain minimum agreed upon stock ownership. The payment terms are $250,000 upon effectiveness and an additional $1,000,000 payable in weekly payments of $6,410.26 from March 8, 2023 through March 6, 2026. The $250,000 was paid into an escrow account with the requirement that they are released to Mr. Klepfish on his separation date. The $1,000,000 portion is in the form of an unsecured, non-interest bearing note payable to Mr. Klepfish. The SK Agreements also call for the delivery of 400,000 shares of the Company’s common stock valued at $168,000 based upon the closing price of the Company’s common stock on Mr. Klepfish’s separation date of February 28, 2023; in addition, for delivery on June 1, 2027 of additional shares of the Company’s common stock equal to the greater of (i) the number of shares with an aggregate fair market value of $400,000 on such date, or (ii) 266,666 shares. The Company also agreed to pay a total of $1,199 of Cobra insurance costs on behalf of Mr. Klepfish over eighteen months. The total amount accrued in connection with the SK Agreements was $1,819,199.

 

On February 28, 2023, the Company entered into a separation agreement (the “Wiernasz Separation Agreement”) with Justin Wiernasz, a director and previous Director of Strategic Acquisitions. Pursuant to the Wiernasz Separation Agreement, the Company agreed to a payment of $100,000 in cash as follows: $33,333 upon execution of the agreement, $33,333 on March 15, 2023, and $33,334 on April 15, 2023. The Company also agreed to make the Cobra insurance payments on behalf of Mr. Wiernasz in the amount of $2,548 per month for twelve months with a maximum of $26,451. The total amount accrued in connection with the Wiernasz Separation Agreement was $126,451.

 

On February 6, 2024, the Company entered into a separation agreement with Richard Tang, its Chief Financial Officer (the “Tang Separation Agreement”) effective as of December 31, 2023. Pursuant to the Tang Separation Agreement, the Company will pay to Mr. Tang, in equal installments over a five month period, the gross sum of $113,918. In addition, Mr. Tang may submit for reimbursement up to $4,000 of legal expenses connected with the review of this separation agreement. The severance payment will be made in the following installments: (i) $25,890 to be paid the week of March 4, 2024; (ii) $5,178 to be paid each successive week for seventeen weeks beginning the week of March 11, 2024, until the Severance Payment is completed. In addition, if Tang timely elects to continue his group health insurance benefits under the Consolidated Omnibus Reconciliation Act (“COBRA”), the Company will reimburse Tang’s group health insurance premiums (“COBRA Premiums”) for the lesser of: (a) the period of time Employee is eligible to continue his group health insurance benefits under COBRA and (b) the five-month period immediately following the Separation Date. Reimbursements will be paid within thirty days of when Tang submits a request for reimbursement and supporting documentation.

 

During the three months ended March 31, 2024, the Company paid cash in the amount of $83,333 to Mr. Klepfish in connection with the SK Agreements.

 

During the three months ended March 31, 2024, the Company made the following payments in connection with the Wiernasz Separation Agreement: The Company made Cobra payments on behalf of Mr. Weirnasz in the amount of $967.

 

During the three months ended March 31, 2024, the Company made the following payments in connection with the Tang Separation agreement: The Company paid cash to Mr. Tang in the amount of $41,125, and made Cobra payments on behalf of Mr. Tang in the amount of $2,885.

 

The following table represents the amounts accrued, paid, and outstanding on these agreements as of March 31, 2024:

 

   

Total

   

Paid / Issued

   

Balance

   

Current

   

Non-current

 

Mr. Klepfish:

                                       

Cash – through March 6, 2026

  $ 1,000,000     $ (358,975 )   $ 641,025     $ 333,333     $ 307,692  

Cash - upon agreement execution

    250,000       (250,000 )     -       -       -  

Stock - June 1, 2027

    400,000       -       400,000       -       400,000  

Stock - Issued in April 2023

    168,000       (168,000 )     -       -       -  

Cobra - over eighteen months

    1,199       -       1,199       1,199       -  

Total – Mr. Klepfish

  $ 1,819,199     $ (776,975 )   $ 1,042,224     $ 334,532     $ 707,692  
                                         

Mr. Wiernasz:

                                       

Cash - three equal payments

  $ 100,000     $ (100,000 )   $ -     $ -     $ -  

Cobra - over eighteen months

    26,451       (26,451 )     -       -       -  

Total - Mr. Wiernasz

  $ 126,451     $ (126,451 )   $ -     $ -     $ -  
                                         

Mr. Tang:

                                       

Cash – over seventeen weeks

  $ 113,918     $ (41,425 )   $ 72,493     $ 72,493     $ -  

Cobra - over five months

    14,495       (2,885 )     11,610       11,610       -  

Total - Mr. Tang

  $ 128,413     $ (44,310 )   $ 84,103     $ 84,103     $ -  
                                         

Total Company

  $ 2,074,063     $ (947,736 )   $ 1,126,327     $ 418,635     $ 707,692  
v3.24.1.1.u2
STOCK APPRECIATION RIGHTS LIABILITY
3 Months Ended
Mar. 31, 2024
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
Other Liabilities Disclosure [Text Block]

13. STOCK APPRECIATION RIGHTS LIABILITY

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its Chief Operating Officer. See note 15. The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense.

 

The change in valuation of the Smallwood SARs is summarized in the table below:

 

May 15, 2023 - fair value

  $ 9,794  

(Gain) Loss on revaluation

    245,226  

December 31, 2023 -fair value

  $ 255,020  

(Gain) Loss on revaluation

    118,898  

March 31, 2024 - fair value

  $ 373,918  
v3.24.1.1.u2
NOTES PAYABLE
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]

14. NOTES PAYABLE

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 13, 2023, the Company entered into a term loan with MapleMark Bank (the “MapleMark Term Loan 3”) in the amount of $9,057,840. Principal and interest due on the MapleMark Term Loan 1 in the amounts of $5,324,733 and $61,715, respectively, were paid with proceeds of the MapleMark Term Loan 3. The MapleMark Term Loan 3 is payable in monthly installments of $80,025 commencing July 1, 2023 and continuing through June 13, 2048.

 

Amounts outstanding under the Maple Mark Term Loan 3 will bear interest at the rate equal to the lesser of (a) the Maximum Lawful Rate, or (b) the greater of (i) WSJP (the “Prime Rate” as published by The Wall Street Journal) plus 1.25% per annum or (ii) 4.50% per annum. At March 31, 2024, the interest rate was 9.50%. The MapleMark Term Loan 3 matures on June 13, 2048.

 

The MapleMark Term Loan 3 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens.

 

The Company created a discount on the MapleMark Term Loan 3 for costs in the amount of $385,803 which will be amortized over the life of the loan. During the three months ended March 31, 2024, the Company amortized $1,284 of these costs to interest expense. During the three months ended March 31, 2024, the Company made principal payments and interest payments in the amount of $22,709 and $221,317, respectively, on this loan. At March 31, 2024, accrued interest on this note was $75,251.

  $ 8,962,933     $ 8,985,642  

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 6, 2022, the Company entered into a term loan agreement with MapleMark (the “MapleMark Term Loan 2”) for the original amount of $356,800. This amount was paid by MapleMark directly to Fifth Third Bank in satisfaction of the outstanding principal and interest due under existing loans with Fifth Third Bank. The MapleMark Term Loan 2 originally matured on May 27, 2023. On June 9, 2023, the USDA approved the Guarantee of MapleMark Term Loan 1 which allowed the Company to extend the term of the MapleMark Term Loan 2 from May 27, 2023 to May 27, 2033 with monthly payments in the amount of approximately $2,311 commencing July 1, 2023 and continuing through June 1, 2033. On July 1, 2033, a final payment in the amount of approximately $303,536 will be due on the MapleMark Term Loan 2.

 

The MapleMark Term Loan 2 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens. The Company recorded a discount to this loan in the amount of $23,367 in connection with financing costs which was amortized to interest expense during the year ended December 31, 2022.

 

On February 14, 2024, The Company sold its Race Track Road Facility in Bonita Springs, Florida, which had been pledged as security for the MapleMark Term Loan 2 (see note 7). Proceeds from the sale in the amount of $352,905 and $910 were used to pay the remaining principal and interest, respectively, on the MapleMark Term Loan 2. At March 31, 2024, there are no amounts due under the MapleMark Term Loan 2.

  $ -     $ 352,905  
                 

A note payable in the amount of $20,000. The Note was due in January 2006 and the Company is currently accruing interest on this note at 1.9%. During the three months ended March 31, 2024, the Company accrued interest in the amount of $96 on this note. At March 31, 2024, accrued interest on this note was $18,578.

  $ 20,000     $ 20,000  

 

Total

  $ 8,982 933     $ 9,358,547  

Discount

    (381,222 )     (382,506 )

Net of discount

  $ 8,601,711     $ 8,976,041  
                 

Current portion

  $ 100,237     $ 121,041  

Long-term maturities, net of discount

    8,501,474       8,855,000  

Total

  $ 8,601,711     $ 8,976,041  

 

There was a total of $93,829 and $95,942 accrued interest on notes payable at March 31, 2024 and December 31, 2023, respectively.

 

Aggregate maturities of notes payable as of March 31, 2024 are as follows:

 

For the period ended March 31,

 

2025

  $ 120,237  

2026

    110,532  

2027

    121,884  

2028

    134,403  

2029

    148,207  

Thereafter

    8,347,670  

Total

  $ 8,982,933  
v3.24.1.1.u2
EQUITY
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Equity [Text Block]

15. EQUITY

 

Common Stock

 

As of March 31, 2024, total common stock issued and outstanding was 52,516,974 and 49,693,803, respectively. As of December 31, 2023, total common stock issued and outstanding was 52,538,100 and 49,714,929, respectively. At March 31, 2024 and December 31, 2023, a total of 2,823,171 shares of common stock were deemed issued but not outstanding.

 

For the three months ended March 31, 2024:

 

Common Stock Received from Sale of Subsidiary

 

On February 26, 2024, the Company sold 100% of the equity interests in Haley for the return of 21,126 shares of the Company’s common stock held by the buyer. (see note 3). The Company Haley had no assets of liabilities at the time of the sale; the Company valued the 21,126 shares of common stock at the market price on the date of the acquisition of $1.00 per sale and recorded a gain in the amount of $21,126 on this transaction.

 

For the three months ended March 31, 2023:

 

On February 28, 2023, the Company issued 267,030 shares with a value of $112,152 to three employees as compensation.

 

During the three months ended March 31, 2023, the Company incurred obligations to issue the following shares of common stock pursuant to employment agreements: an aggregate total of 400,007 shares of common stock with a market value of $93,600 were accrued for issuance to its previous Chief Executive Officer; of this amount, 207,839 with a market value of $52,919 were withheld for the payment of income taxes, and the net number of shares issuable to the previous Chief Executive Officer was 192,168 with a market value of $45,680. Also during the period, an aggregate total of 15,106 shares of common stock with a market value of $5,000 were accrued for issuance to two board members, and $19,428 was expensed during the quarter for the share based plan for the Chief Executive Officer (see below). These restricted stock grants are being amortized over their vesting periods of one to three years. During the three months ended March 31, 2023, the total amount of $178,048 was charged to non-cash compensation and $52,919 was charged to cash compensation in connection with these grants.

 

Share based executive compensation plans

 

CEO Stock Plan

 

On February 3, 2023, the Company entered into an employment agreement with Bill Bennett to become the Company’s CEO. On November 3, 2023, the Company recognized that the hiring of Mr. Bennett was protracted, and the original employment agreement calculated the number of Shares to be granted in connection with the Executive Compensation Plan on the basis of the number of Shares outstanding as of October 2022, which did not take into consideration the number of shares that were issued to a departing executive and to certain other employees of the Company thereafter. Accordingly, the number of shares issuable to Mr. Bennett at each price target was adjusted, effective as of the original date of the plan. Pursuant to this agreement, Mr. Bennett was provided with an incentive compensation plan (the “CEO Stock Plan”) whereby Mr. Bennett would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.60       2.00 %     975,133  
$ 0.80       1.50 %     731,350  
$ 1.00       1.00 %     487,567  
$ 1.20       0.75 %     365,675  
$ 1.40       0.75 %     365,675  
$ 1.60       0.50 %     243,783  
$ 1.80       0.50 %     243,783  
$ 2.00       0.50 %     243,783  

 

The value of the plan was determined to be $660,541. This amount will be recorded as a charge to additional paid-in capital on a straight-line basis over 34 months. During the three months ended March 31, 2024, the amounts of $58,283 was charged to operations pursuant to the CEO Stock Plan.

 

On November 7, 2023, the Company issued 678,302 shares of common stock, net of 296,831 shares withheld for income tax purposes, to its Chief Executive Officer pursuant the achievement of the first price target in the CEO Stock Plan.

 

On March 19, 2024, the Company’s stock price attained the second price target in the CEO Stock Plan, and Mr. Bennett became eligible to receive 731,350 shares of the Company’s common stock. These shares have not been issued as of March 31, 2024.

 

COO Stock Plan

 

On April 14, 2023, the Company entered into an employment agreement with Brady Smallwood to become the Company’s COO effective May 15, 2023. Pursuant to this agreement, Mr. Smallwood was provided with an incentive compensation plan (the “COO Stock Plan”) whereby Mr. Smallwood would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.87       0.40 %     196,627  
$ 1.16       0.30 %     147,470  
$ 1.45       0.20 %     98,313  
$ 1.74       0.15 %     73,735  
$ 2.03       0.15 %     73,735  
$ 2.32       0.10 %     49,157  
$ 2.61       0.10 %     49,157  
$ 2.90       0.10 %     49,157  

 

The value of the plan was determined to be $199,951. This amount will be recorded as a charge to additional paid-in capital on a straight-line basis over 31.5 months. During the three months ended March 31, 2024, the amount of $19,043 was charged to operations pursuant to the COO Stock Plan. At March 31, 2024, none of the price targets under the COO Stock Plan have been achieved.

 

CFO Stock Plan

 

On December 29, 2023, the Company entered into an employment agreement with Gary Schubert to become the Company’s CFO effective January 1, 2024. Pursuant to this agreement, Mr. Schubert was provided with an incentive compensation plan (the “CFO Stock Plan”) whereby Mr. Schubert would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 1.23       0.40 %     131,085  
$ 1.63       0.30 %     98,313  
$ 2.04       0.20 %     65,542  
$ 2.45       0.15 %     49,157  
$ 2.86       0.15 %     49,157  
$ 3.27       0.10 %     32,771  
$ 3.68       0.10 %     32,771  
$ 4.08       0.10 %     32,771  

 

The CFO Stock Plan had a fair value of $238,747 at inception (see “Stock Plan Valuation” section below). This amount will be amortized over the 30-month life of the plan beginning January 1, 2024. During the three months ended March 31, 2024, $23,875 of this amount was charged to operations. At March 31, 2024, none of the price targets under the COO Stock Plan have been achieved.

 

The Company relied upon the guidance of Statement of Financial Account Standards No. 718 Compensation – Stock Compensation (“ASC 718”) in accounting for the CEO, COO, and CFO Stock Plans. A Monte Carlo market-based performance stock awards model was used in valuing the plan, with the following assumptions:

 

 

The stock price for each trading day would fluctuate with an estimated projected volatility using a normal distribution. The stock price of the underlying instrument is modeled such that it follows a geometric Brownian motion with constant drift and volatility.

 

 

 

 

The Company would award the stock upon triggering the thresholds.

 

 

 

 

Annual attrition or forfeiture rates (i.e., pre–vesting forfeiture assumption) are assumed to be zero given the Holder’s position with the Company.

 

 

 

 

No Projected capital events were included in the adjustments to the shares issued and outstanding in the projected simulations.

 

 

 

 

Awards/Payouts were discounted at the risk–free rate.

 

The CEO, COO, and CFO Stock Plans were valued utilizing the following:

 

   

December 31, 2023

Volatility

    103.9%-113.7%

Dividends

  $

Risk-free interest rates

    4.45%-4.45%

Expected term (years)

    2.63-2.91 

 

Stock Appreciation Rights

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its Chief Operating Officer. The Smallwood SARs vest upon issuance, and expire on December 31, 2026; 750,000 of the Smallwood SARs are priced at $1.50 per share, and 750,000 are priced at $2.00 per share. It is the Company’s intention to settle the Smallwood SARs in cash if the stock price exceeds the $1.50 and $2.00 per share price prior to the expiration date. The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense. At March 31, 2024, the Smallwood SARs had a fair value of $373,918; the increase in fair value in the amount $118,898 during the three months ended March 31, 2024 was charged to non-cash compensation. See note 13.

 

The Smallwood SARs were valued using the Black-Scholes valuation model utilizing the following variables:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 

Volatility

    86.58 %     45.0-53.3 %

Dividends

  $ -     $ -  

Risk-free interest rates

    4.59 %     3.67-4.87 %

Term (years)

    2.75       2.63-2.51  

 

Options

 

The following table summarizes the options outstanding at March 31, 2024 and the related prices for the options to purchase shares of the Company’s common stock issued by the Company:

 

                       

Weighted

           

Weighted

 
               

Weighted

   

average

           

average

 
               

average

   

exercise

           

exercise

 

Range of

   

Number of

   

Remaining

   

price of

   

Number of

   

price of

 

exercise

   

options

   

contractual

   

outstanding

   

options

   

exercisable

 

Prices

   

Outstanding

   

life (years)

   

Options

   

Exercisable

   

Options

 
$ 0.41       125,000       0.07     $ 0.41       125,000     $ 0.41  
$ 0.50       125,000       0.07     $ 0.50       125,000     $ 0.50  
$ 0.60       50,000       1.75     $ 0.60       43,750     $ 0.60  
$ 1.00       50,000       1.75     $ 1.00       43,750     $ 1.00  
$ 1.25       130,000       2.25     $ 1.25       -     $ -  
$ 1.75       130,000       2.25     $ 1.75       -     $ -  
          610,000       1.27     $ 0.96       350,000     $ 0.55  

 

Transactions involving stock options are summarized as follows:

 

   

Number of Shares

   

Weighted Average

Exercise Price

 

Options outstanding at December 31, 2023

    350,000     $ 0.55  
                 

Granted

    260,000     $ 1.50  

Exercised

    -     $ -  

Cancelled / Expired

    -     $ -  
                 

Options outstanding at March 31, 2024 (unaudited)

    610,000     $ 0.96  

Options exercisable at March 31, 2024 (unaudited)

    350,000     $ 0.55  

 

Aggregate intrinsic value of options outstanding and exercisable at March 31, 2024 was $156,075. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the fiscal period, which was $1.00 at March 31, 2024, and the exercise price multiplied by the number of options outstanding.

 

During the three months ended March 31, 2024 and 2023, the Company charged the amount of $2,034 and $0, respectively, to operations for the vesting of stock options.

v3.24.1.1.u2
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]

16. RELATED PARTY TRANSACTIONS

 

Payments to Prior Executive Officers under Separation Agreements

 

During the three months ended March 31, 2024, the Company made the following payments to previous Executive Officers in connection with separation agreements (see note 12):

 

The Company paid cash in the amount of $83,333 to Mr. Klepfish, its prior CEO.

 

The Company made Cobra payments on behalf of Mr. Weirnasz, its prior Director of Strategic Acquisitions and previous board member, in the amount of $967.

 

The Company made cash payments to Mr. Tang, its prior CFO, in the amount of $41,125, and made Cobra payments on behalf of Mr. Tang in the amount of $2,885.

v3.24.1.1.u2
MAJOR CUSTOMERS
3 Months Ended
Mar. 31, 2024
Risks and Uncertainties [Abstract]  
Concentration Risk Disclosure [Text Block]

17. MAJOR CUSTOMERS

 

The Company’s largest customer, U.S. Foods, Inc. and its affiliates, accounted for approximately 49% and 47% of total sales in the three months ended March 31, 2024 and 2023, respectively. In addition, Gate Gourmet, the leading global provider of airline catering solutions and provisioning services for airlines, in partnership with igourmet, represented 17% and 16% of total sales for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.1.u2
COMMITMENTS AND CONTINGENT LIABILITIES
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]

18. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

On September 16, 2019, an action (the “PA Action”) was filed in the Court of Common Pleas of Philadelphia County, Trial Division, against, among others, the Company and its wholly-owned subsidiaries, igourmet and Food Innovations, Inc. On January 5, 2024, all parties to the PA Action came to an agreement at Mediation on the material terms of settlement and on January 22, 2024, a settlement was agreed upon in an action filed in the Court of Common Pleas of Philadelphia County, Trial Division against, among others, the Company and its wholly owned subsidiaries, igourmet and Food Innovations, Inc. On Monday, January 29, 2024, the Company received a settlement and release agreement from certain plaintiffs in the PA Action. The Company and its subsidiaries resolved all liabilities within the coverages of their insurance carriers.

 

From time to time, the Company has become and may become involved in certain lawsuits and legal proceedings which arise in the ordinary course of business, or as the result of current or previous investments, or current or previous subsidiaries, or current or previous employees, or current or previous directors, or as a result of acquisitions and dispositions or other corporate activities. The Company intends to vigorously defend its positions. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our financial position or our business and the outcome of these matters cannot be ultimately predicted.

v3.24.1.1.u2
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events [Text Block]

19. SUBSEQUENT EVENTS

 

Share Incentive Plan Performance Goal Achieved

 

On April 17, 2024, the Company’s stock price achieved the first price target of $0.87 under the COO Stock Plan and the Company became obligated to issue a total of 196,627 shares to its COO.

v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ 1,425,874 $ (2,828,766)
v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.1.u2
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]

Business Activity

We provide difficult-to-find specialty foods primarily to both Professional Chefs and Home Gourmets through our relationships with producers, growers, makers and distributors of these products worldwide. The distribution of these products primarily originates from our three unified warehouses and those of our drop ship partners, and is driven by our proprietary technology platform. In addition, we provide value-added services through our team of food specialists and Chef Advisors who offer customer support, menu ideas, and preparation guidance.

Restructuring

During the fourth quarter of 2023 we made the decision to focus more on our Business to Business (B2B) activities and less on our Direct to Consumer (D2C) products. Our subsidiaries GROW and Oasis were sold effective December 29, 2023; Haley was sold effective February 26, 2024; and the activities of P Innovations will be abandoned. Our remaining D2C business, primarily operated within igourmet and Mouth, will be downsized. See note 2.

Discontinued Operations, Policy [Policy Text Block]

Discontinued Operations

Pursuant to the guidance of ASC 205-20 Presentation of Financial Statements Discontinued Operations, the accounts of our discontinued entities GROW, Oasis, Haley, and P Innovations have been included in “Net loss from discontinued operations” in our consolidated statements of operations until such time as each entity was sold. Additionally, the assets and liabilities of these entities have been presented as discontinued operations in our consolidated balance sheets as of March 31, 2024 and December 31, 2023 until such time as each entity was sold. See Note 2.

Reclassification, Comparability Adjustment [Policy Text Block]

Reclassifications

Certain amounts presented in the financial statements of the prior period have been reclassified to conform with the current period presentation of discontinued operations. See note 2.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of these unaudited consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, inventory reserves, income taxes, intangible assets, operating and finance right of use assets and liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

 

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentrations of Credit Risk

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash in investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limit. At March 31, 2024 and 2023, trade receivables from the Company’s largest customer amounted to 32% and 23%, respectively, of total trade receivables. During the three months ended March 31, 2024 and 2023, sales from the Company’s largest customer amounted to 49% and 47% of total sales, respectively.

The Company maintains cash balances in excess of Federal Deposit Insurance Corporation limits. At March 31, 2024 and December 31, 2023, the total cash in excess of these limits was $931,857 and $988,825, respectively.

Receivable [Policy Text Block]

Accounts Receivable

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts pursuant to the guidance of Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326) as codified in Accounts Standards Codification (ASC) 326, Financial Instruments – Credit Losses. Under ASC 326, the Company utilizes a current and expected credit loss (CECL) impairment model. ASU 2016-13 became effective for us on January 1, 2023. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. Accounts receivable are presented net of an allowance for doubtful accounts of $69,359 and $46,477 at March 31, 2024 and December 31, 2023, respectively.

Lessee, Leases [Policy Text Block]

Leases

The Company accounts for leases in accordance with Financial Accounting Standards Board (“FASB”) ASC 842, “Leases”. The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets (“ROU assets”) and short-term and long-term lease liabilities are included on the face of the consolidated balance sheet. Finance lease ROU assets are presented within other assets, and finance lease liabilities are presented within current and long-term liabilities.

ROU assets represent the right of use to an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For lease agreements with terms less than 12 months, the Company has elected the short-term lease measurement and recognition exemption, and it recognizes such lease payments on a straight-line basis over the lease term.

Revenue [Policy Text Block]

Revenue Recognition

The Company recognizes revenue upon product delivery. All of our products are shipped either same day or overnight or through longer shipping terms to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues.

For revenue from product sales (i.e., specialty foodservice and e-commerce), the Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers”. A five-step analysis must be met as outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

Warehouse and logistic services revenue is primarily comprised of inventory management, order fulfilment and warehousing services. Warehouse & logistics services revenues are recognized at the point in time when the services are rendered to the customer.

 

Revenue from Contract with Customer [Policy Text Block]

Deferred Revenue

Certain customer arrangements in the Company’s business such as gift cards and e-commerce subscription purchases result in deferred revenues when cash payments are received in advance of performance. Gift cards issued by the Company generally have an expiration of five years from date of purchase. The Company records a liability for unredeemed gift cards and advance payments for monthly club memberships as cash is received, and the liability is reduced when the card is redeemed or product delivered.

The following table represents the changes in deferred revenue as reported on the Company’s consolidated balance sheets:

Balance as of December 31, 2022

  $ 1,558,155  

Cash payments received

    215,346  

Net sales recognized

    (534,711 )

Balance as of March 31, 2023 (unaudited)

  $ 1,238,790  

Balance as of December 31, 2023

  $ 1,312,837  

Cash payments received

    4,033,077  

Net sales recognized

    (4,117,978 )

Balance as of March 31, 2024 (unaudited)

  $ 1,227,936  
Long-Duration Contracts Revenue Recognition, Policy [Policy Text Block]

Disaggregation of Revenue

The following table represents a disaggregation of revenue for the three months ended March 31, 2024 and 2023:

   

Three Months Ended

 
   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Specialty Foodservice

  $ 13,993,565     $ 13,804,785  

E-Commerce

    1,528,337       2,621,405  

Logistics

    208,211       248,569  

Total

  $ 15,730,113     $ 16,674,759  
Cost of Goods and Service [Policy Text Block]

Cost of goods sold

We have included in cost of goods sold all costs which are directly related to the generation of revenue. These costs include primarily the cost of food and raw materials, packing and handling, shipping, and delivery costs.

We have also included all payroll costs as cost of goods sold in our leasing and logistics services business.

Earnings Per Share, Policy [Policy Text Block]

Basic and Diluted Earnings Per Share

Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully-diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during the period.

The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation.

 

Dilutive shares at March 31, 2024:

Stock Options

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2024:

               

Weighted

 
               

average

 
               

Remaining

 

Exercise

   

Number of

   

contractual

 

Price

   

Options

   

life (years)

 
$ 0.41       125,000       0.07  
$ 0.50       125,000       0.07  
$ 0.60       50,000       1.75  
$ 1.00       50,000       1.75  
$ 1.25       130,000       2.25  
$ 1.75       130,000       2.25  
          610,000       1.27  

Restricted Stock Awards

At March 31, 2024, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. The fair value of these RSUs at the date of the grants will be charged to operations upon vesting. At March 31, 2024, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2024.

Stock-based Compensation

At March 31, 2024, there were a total of 3,910,534 shares of common stock potentially issuable to the Company’s executive officers pursuant to compensation plans and contingent upon the achievement of certain performance goals; see notes 15 and 16.

Dilutive shares at March 31, 2023:

Stock Options

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2023:

               

Weighted

 
               

Average

 
               

Remaining

 

Exercise

   

Number

   

Contractual

 

Price

   

of Options

   

Life (years)

 
$ 0.41       125,000       1.07  
$ 0.50       125,000       1.07  
$ 0.60       50,000       2.75  
$ 0.62       360,000       0.75  
$ 0.85       540,000       0.75  
$ 1.00       50,000       2.75  
$ 1.20       950,000       0.74  
          2,200,000       0.87  

 

Restricted Stock Awards

At March 31, 2023, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. At March 31, 2023, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2023.

Stock-based Compensation

At March 31, 2023, there were a total of 3,538,243 shares of common stock potentially issuable to the Company’s Chief Executive Officer pursuant to his compensation plan and contingent upon the achievement of certain performance goals. see notes 15 and 16.

New Accounting Pronouncements, Policy [Policy Text Block]

New Accounting Pronouncements

Management does not believe that any other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

v3.24.1.1.u2
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Deferred Revenue, by Arrangement, Disclosure [Table Text Block] The following table represents the changes in deferred revenue as reported on the Company’s consolidated balance sheets:

Balance as of December 31, 2022

  $ 1,558,155  

Cash payments received

    215,346  

Net sales recognized

    (534,711 )

Balance as of March 31, 2023 (unaudited)

  $ 1,238,790  

Balance as of December 31, 2023

  $ 1,312,837  

Cash payments received

    4,033,077  

Net sales recognized

    (4,117,978 )

Balance as of March 31, 2024 (unaudited)

  $ 1,227,936  
Disaggregation of Revenue [Table Text Block] The following table represents a disaggregation of revenue for the three months ended March 31, 2024 and 2023:
   

Three Months Ended

 
   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Specialty Foodservice

  $ 13,993,565     $ 13,804,785  

E-Commerce

    1,528,337       2,621,405  

Logistics

    208,211       248,569  

Total

  $ 15,730,113     $ 16,674,759  
Dilutive Shares [Table Text Block] The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2024:
               

Weighted

 
               

average

 
               

Remaining

 

Exercise

   

Number of

   

contractual

 

Price

   

Options

   

life (years)

 
$ 0.41       125,000       0.07  
$ 0.50       125,000       0.07  
$ 0.60       50,000       1.75  
$ 1.00       50,000       1.75  
$ 1.25       130,000       2.25  
$ 1.75       130,000       2.25  
          610,000       1.27  
               

Weighted

 
               

Average

 
               

Remaining

 

Exercise

   

Number

   

Contractual

 

Price

   

of Options

   

Life (years)

 
$ 0.41       125,000       1.07  
$ 0.50       125,000       1.07  
$ 0.60       50,000       2.75  
$ 0.62       360,000       0.75  
$ 0.85       540,000       0.75  
$ 1.00       50,000       2.75  
$ 1.20       950,000       0.74  
          2,200,000       0.87  

 

v3.24.1.1.u2
DISCONTINUED OPERATIONS (Tables)
3 Months Ended
Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations [Table Text Block] The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets:
   

March 31,

   

December 31,

 
   

2024

   

2023

 

Current assets - discontinued operations:

 

(unaudited)

         

Cash

  $ 19,973     $ 95,319  

Accounts receivable

    635       501  

Inventory

    41       41  

Other current assets

    -       -  

Total current assets - discontinued operations

  $ 20,649     $ 95,861  
                 

Current liabilities - discontinued operations:

               

Accounts payable and accrued liabilities

  $ -     $ 986  

Accrued payroll and related liabilities

    -       3,267  

Deferred revenue

    2,522       2,169  

Total current liabilities - discontinued operations

  $ 2,522     $ 6,422  
   

Three Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 

Revenue

  $ 24,856     $ 320,441  

Cost of goods sold

    (2,238 )     (8,080 )

Gross margin

    22,618       312,361  
                 

Selling, general, and administrative expenses

    (32,723 )     (354,692 )
                 

Interest income

    -       280  

Loss from discontinued operations, net of tax

  $ (10,105 )   $ (42,051 )

 

v3.24.1.1.u2
ACCOUNTS RECEIVABLE (Tables)
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] At March 31, 2024 and December 31, 2023, accounts receivable consists of:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Accounts receivable from customers

  $ 4,178,633     $ 4,354,203  
Allowance for doubtful accounts     (69,359 )     (46,477 )

Accounts receivable, net

  $ 4,109,274     $ 4,307,726  
v3.24.1.1.u2
INVENTORY (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block] Inventory consists primarily of specialty food products. At March 31, 2024 and December 31, 2023, inventory consisted of the following:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Finished goods inventory

  $ 2,840,682     $ 2,973,134  

Allowance for slow moving & obsolete inventory

    -       -  

Finished goods inventory, net

  $ 2,840,682     $ 2,973,134  
v3.24.1.1.u2
PROPERTY AND EQUIPMENT (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block] A summary of property and equipment at March 31, 2024 and December 31, 2023 is as follows:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Land

  $ 208,140     $ 1,079,512  

Building

    711,409       6,571,496  

Computer and Office Equipment

    599,242       597,834  

Warehouse Equipment

    477,090       477,090  

Furniture and Fixtures

    940,960       940,960  

Vehicles

    58,353       58,353  

Total before accumulated depreciation

    2,995,194       9,725,245  

Less: accumulated depreciation

    (2,021,051 )     (2,725,230 )

Total

  $ 974,143     $ 7,000,015  
v3.24.1.1.u2
PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE (Tables)
3 Months Ended
Mar. 31, 2024
Property And Equipment Held For Sale Disclosure Abstract  
Disclosure of Long-Lived Assets Held-for-Sale [Table Text Block] The net book value of these assets consisted of the following at March 31, 2024 and December 31, 2023:
   

March 31,

   

December 31,

 
   

2024

   

2023

 
                 

Land

  $ 871,372     $ 177,383  

Building

    5,070,561       431,147  

Furniture, fixtures, and equipment

    -       41,314  

Total

  $ 5,941,933     $ 649,844  
v3.24.1.1.u2
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Tables)
3 Months Ended
Mar. 31, 2024
Disclosure Text Block [Abstract]  
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table Text Block] Right of use assets – operating leases are summarized below:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Right of use assets, net

  $ 24,344     $ 28,519  
Lease, Cost [Table Text Block] Operating lease liabilities are summarized below:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Lease liability

  $ 24,344     $ 28,519  

Less: current portion

    (17,422 )     (17,131 )

Lease liability, non-current

  $ 6,922     $ 11,388  

 

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Maturity analysis under these lease agreements are as follows:

For the period ended March 31, 2025

  $ 18,532  

For the period ended March 31, 2026

    7,051  

Total

  $ 25,583  

Less: Present value discount

    (1,239 )

Lease liability

  $ 24,344  
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES (Tables)
3 Months Ended
Mar. 31, 2024
Disclosure Text Block [Abstract]  
Lease, Cost [Table Text Block] The Company has financing leases for vehicles and warehouse equipment. Right of use asset – financing leases are summarized below:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Vehicles

  $ 404,858     $ 404,858  

Warehouse Equipment

    555,416       555,416  

Total before accumulated depreciation

    960,274       960,274  

Less: accumulated depreciation

    (548,786 )     (523,871 )

Total

  $ 411,488     $ 436,403  
Finance Lease [Table Text Block]
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a forklift dated July 12, 2021 in the original amount of $16,070 payable in thirty-six monthly installments of $489 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $1,431 and $36, respectively.

  $ 1,453     $ 2,884  
                 

Financing lease obligation under a lease agreement for a pallet truck dated July 15, 2021 in the original amount of $5,816 payable in thirty-six monthly installments of $177 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $518 and $13, respectively.

  $ 526     $ 1,044  
                 

Financing lease obligation under a lease agreement for warehouse furniture and equipment truck dated October 14, 2020 in the original amount of $514,173 payable in sixty monthly installments of $9,942 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amount of $19,084 and $2,834, respectively.

  $ 170,712     $ 197,707  

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a truck dated March 31, 2020 in the original amount of $152,548 payable in eighty-four monthly installments of $2,188 including interest at the rate of 5.44%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,552 and $1,012, respectively.

  $ 70,666     $ 76,218  
                 

Financing lease obligation under a lease agreement for a truck dated November 5, 2018 in the original amount of $128,587 payable in seventy monthly installments of $2,326 including interest at the rate of 8.33%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $6,647 and $330, respectively.

    11,388     $ 18,035  
                 

Financing lease obligation under a lease agreement for a truck dated August 23, 2019 in the original amount of $80,413 payable in eighty-four monthly installments of $1,148 including interest at the rate of 5.0%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $3,040 and $404, respectively.

  $ 30,282     $ 33,322  
                 

Financing lease obligation under a lease agreement for a truck dated February 4, 2022 in the original amount of $42,500 payable in twenty-four monthly installments of $1,963 including interest at the rate of 10.1%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,794 and $98, respectively.

  $ -     $ 5,794  
                 

Total

  $ 285,027     $ 335,004  
                 

Current portion

  $ 136,096     $ 115,738  

Long-term maturities

    148,931       219,266  

Total

  $ 285,027     $ 335,004  
Finance Lease, Liability, to be Paid, Maturity [Table Text Block] Aggregate maturities of lease liabilities:

2025

  $ 160,993  

2026

    96,060  

2027

    27,974  

Total

  $ 285,027  
v3.24.1.1.u2
INTANGIBLE ASSETS (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets and Goodwill [Table Text Block] The following is the net book value of these assets:
   

March 31, 2024

(unaudited)

 
           

Accumulated

         
   

Gross

   

Amortization

   

Net

 

Trade Names

  $ 217,000     $ -     $ 217,000  
   

December 31, 2023

 
           

Accumulated

         
   

Cost

   

Amortization

   

Net

 

Total Trade Names

  $ 217,000     $ -     $ 217,000  
v3.24.1.1.u2
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Accounts payable and accrued liabilities at March 31, 2024 and December 31, 2023 are as follows:
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Trade payables and accrued liabilities

  $ 2,955,157     $ 6,046,396  

Accrued payroll and commissions

    156,514       206,555  

Total

  $ 3,111,671     $ 6,252,951  
v3.24.1.1.u2
ACCRUED SEPARATION COSTS – RELATED PARTIES (Tables)
3 Months Ended
Mar. 31, 2024
Compensation Related Costs [Abstract]  
Schedule of Related Party Transactions [Table Text Block] The following table represents the amounts accrued, paid, and outstanding on these agreements as of March 31, 2024:
   

Total

   

Paid / Issued

   

Balance

   

Current

   

Non-current

 

Mr. Klepfish:

                                       

Cash – through March 6, 2026

  $ 1,000,000     $ (358,975 )   $ 641,025     $ 333,333     $ 307,692  

Cash - upon agreement execution

    250,000       (250,000 )     -       -       -  

Stock - June 1, 2027

    400,000       -       400,000       -       400,000  

Stock - Issued in April 2023

    168,000       (168,000 )     -       -       -  

Cobra - over eighteen months

    1,199       -       1,199       1,199       -  

Total – Mr. Klepfish

  $ 1,819,199     $ (776,975 )   $ 1,042,224     $ 334,532     $ 707,692  
                                         

Mr. Wiernasz:

                                       

Cash - three equal payments

  $ 100,000     $ (100,000 )   $ -     $ -     $ -  

Cobra - over eighteen months

    26,451       (26,451 )     -       -       -  

Total - Mr. Wiernasz

  $ 126,451     $ (126,451 )   $ -     $ -     $ -  
                                         

Mr. Tang:

                                       

Cash – over seventeen weeks

  $ 113,918     $ (41,425 )   $ 72,493     $ 72,493     $ -  

Cobra - over five months

    14,495       (2,885 )     11,610       11,610       -  

Total - Mr. Tang

  $ 128,413     $ (44,310 )   $ 84,103     $ 84,103     $ -  
                                         

Total Company

  $ 2,074,063     $ (947,736 )   $ 1,126,327     $ 418,635     $ 707,692  
v3.24.1.1.u2
STOCK APPRECIATION RIGHTS LIABILITY (Tables)
3 Months Ended
Mar. 31, 2024
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
Change in valuation of stock appreciation rights [TableTextBlock] The change in valuation of the Smallwood SARs is summarized in the table below:

May 15, 2023 - fair value

  $ 9,794  

(Gain) Loss on revaluation

    245,226  

December 31, 2023 -fair value

  $ 255,020  

(Gain) Loss on revaluation

    118,898  

March 31, 2024 - fair value

  $ 373,918  
v3.24.1.1.u2
NOTES PAYABLE (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt [Table Text Block]
   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 13, 2023, the Company entered into a term loan with MapleMark Bank (the “MapleMark Term Loan 3”) in the amount of $9,057,840. Principal and interest due on the MapleMark Term Loan 1 in the amounts of $5,324,733 and $61,715, respectively, were paid with proceeds of the MapleMark Term Loan 3. The MapleMark Term Loan 3 is payable in monthly installments of $80,025 commencing July 1, 2023 and continuing through June 13, 2048.

 

Amounts outstanding under the Maple Mark Term Loan 3 will bear interest at the rate equal to the lesser of (a) the Maximum Lawful Rate, or (b) the greater of (i) WSJP (the “Prime Rate” as published by The Wall Street Journal) plus 1.25% per annum or (ii) 4.50% per annum. At March 31, 2024, the interest rate was 9.50%. The MapleMark Term Loan 3 matures on June 13, 2048.

 

The MapleMark Term Loan 3 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens.

 

The Company created a discount on the MapleMark Term Loan 3 for costs in the amount of $385,803 which will be amortized over the life of the loan. During the three months ended March 31, 2024, the Company amortized $1,284 of these costs to interest expense. During the three months ended March 31, 2024, the Company made principal payments and interest payments in the amount of $22,709 and $221,317, respectively, on this loan. At March 31, 2024, accrued interest on this note was $75,251.

  $ 8,962,933     $ 8,985,642  

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 6, 2022, the Company entered into a term loan agreement with MapleMark (the “MapleMark Term Loan 2”) for the original amount of $356,800. This amount was paid by MapleMark directly to Fifth Third Bank in satisfaction of the outstanding principal and interest due under existing loans with Fifth Third Bank. The MapleMark Term Loan 2 originally matured on May 27, 2023. On June 9, 2023, the USDA approved the Guarantee of MapleMark Term Loan 1 which allowed the Company to extend the term of the MapleMark Term Loan 2 from May 27, 2023 to May 27, 2033 with monthly payments in the amount of approximately $2,311 commencing July 1, 2023 and continuing through June 1, 2033. On July 1, 2033, a final payment in the amount of approximately $303,536 will be due on the MapleMark Term Loan 2.

 

The MapleMark Term Loan 2 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens. The Company recorded a discount to this loan in the amount of $23,367 in connection with financing costs which was amortized to interest expense during the year ended December 31, 2022.

 

On February 14, 2024, The Company sold its Race Track Road Facility in Bonita Springs, Florida, which had been pledged as security for the MapleMark Term Loan 2 (see note 7). Proceeds from the sale in the amount of $352,905 and $910 were used to pay the remaining principal and interest, respectively, on the MapleMark Term Loan 2. At March 31, 2024, there are no amounts due under the MapleMark Term Loan 2.

  $ -     $ 352,905  
                 

A note payable in the amount of $20,000. The Note was due in January 2006 and the Company is currently accruing interest on this note at 1.9%. During the three months ended March 31, 2024, the Company accrued interest in the amount of $96 on this note. At March 31, 2024, accrued interest on this note was $18,578.

  $ 20,000     $ 20,000  

Total

  $ 8,982 933     $ 9,358,547  

Discount

    (381,222 )     (382,506 )

Net of discount

  $ 8,601,711     $ 8,976,041  
                 

Current portion

  $ 100,237     $ 121,041  

Long-term maturities, net of discount

    8,501,474       8,855,000  

Total

  $ 8,601,711     $ 8,976,041  
Schedule of Maturities of Long-Term Debt [Table Text Block] Aggregate maturities of notes payable as of March 31, 2024 are as follows:

2025

  $ 120,237  

2026

    110,532  

2027

    121,884  

2028

    134,403  

2029

    148,207  

Thereafter

    8,347,670  

Total

  $ 8,982,933  
v3.24.1.1.u2
EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
EQUITY (Tables) [Line Items]  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

December 31, 2023

Volatility

    103.9%-113.7%

Dividends

  $

Risk-free interest rates

    4.45%-4.45%

Expected term (years)

    2.63-2.91 
   

March 31,

   

December 31,

 
   

2024

   

2023

 

Volatility

    86.58 %     45.0-53.3 %

Dividends

  $ -     $ -  

Risk-free interest rates

    4.59 %     3.67-4.87 %

Term (years)

    2.75       2.63-2.51  
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] The following table summarizes the options outstanding at March 31, 2024 and the related prices for the options to purchase shares of the Company’s common stock issued by the Company:
                       

Weighted

           

Weighted

 
               

Weighted

   

average

           

average

 
               

average

   

exercise

           

exercise

 

Range of

   

Number of

   

Remaining

   

price of

   

Number of

   

price of

 

exercise

   

options

   

contractual

   

outstanding

   

options

   

exercisable

 

Prices

   

Outstanding

   

life (years)

   

Options

   

Exercisable

   

Options

 
$ 0.41       125,000       0.07     $ 0.41       125,000     $ 0.41  
$ 0.50       125,000       0.07     $ 0.50       125,000     $ 0.50  
$ 0.60       50,000       1.75     $ 0.60       43,750     $ 0.60  
$ 1.00       50,000       1.75     $ 1.00       43,750     $ 1.00  
$ 1.25       130,000       2.25     $ 1.25       -     $ -  
$ 1.75       130,000       2.25     $ 1.75       -     $ -  
          610,000       1.27     $ 0.96       350,000     $ 0.55  
Share-Based Payment Arrangement, Option, Activity [Table Text Block] Transactions involving stock options are summarized as follows:
   

Number of Shares

   

Weighted Average

Exercise Price

 

Options outstanding at December 31, 2023

    350,000     $ 0.55  
                 

Granted

    260,000     $ 1.50  

Exercised

    -     $ -  

Cancelled / Expired

    -     $ -  
                 

Options outstanding at March 31, 2024 (unaudited)

    610,000     $ 0.96  

Options exercisable at March 31, 2024 (unaudited)

    350,000     $ 0.55  
Chief Executive Officer [Member]  
EQUITY (Tables) [Line Items]  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.60       2.00 %     975,133  
$ 0.80       1.50 %     731,350  
$ 1.00       1.00 %     487,567  
$ 1.20       0.75 %     365,675  
$ 1.40       0.75 %     365,675  
$ 1.60       0.50 %     243,783  
$ 1.80       0.50 %     243,783  
$ 2.00       0.50 %     243,783  
Chief Operating Officer [Member]  
EQUITY (Tables) [Line Items]  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.87       0.40 %     196,627  
$ 1.16       0.30 %     147,470  
$ 1.45       0.20 %     98,313  
$ 1.74       0.15 %     73,735  
$ 2.03       0.15 %     73,735  
$ 2.32       0.10 %     49,157  
$ 2.61       0.10 %     49,157  
$ 2.90       0.10 %     49,157  
Chief Financial Officer [Member]  
EQUITY (Tables) [Line Items]  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 1.23       0.40 %     131,085  
$ 1.63       0.30 %     98,313  
$ 2.04       0.20 %     65,542  
$ 2.45       0.15 %     49,157  
$ 2.86       0.15 %     49,157  
$ 3.27       0.10 %     32,771  
$ 3.68       0.10 %     32,771  
$ 4.08       0.10 %     32,771  
v3.24.1.1.u2
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Cash, Uninsured Amount (in Dollars) $ 931,857   $ 988,825
Accounts Receivable, Allowance for Credit Loss (in Dollars) $ 69,359   $ 46,477
U.S. Foods, Inc. [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Concentration Risk, Percentage 32.00% 23.00%  
U.S. Foods, Inc. [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Concentration Risk, Percentage 49.00% 47.00%  
Chief Executive Officer [Member]      
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture 3,910,534 3,538,243  
Restricted Stock [Member]      
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number 300,000 300,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted 300,000 300,000  
Restricted Stock [Member] | Share-Based Payment Arrangement, Tranche One [Member]      
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted 125,000 125,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days  
Restricted Stock [Member] | Share-Based Payment Arrangement, Tranche Two [Member]      
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number 175,000 175,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days  
v3.24.1.1.u2
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Deferred Revenue, by Arrangement, Disclosure - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Deferred Revenue By Arrangement Disclosure Abstract    
Balance $ 1,312,837 $ 1,558,155
Cash payments received 4,033,077 215,346
Net sales recognized (4,117,978) (534,711)
Balance $ 1,227,936 $ 1,238,790
v3.24.1.1.u2
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Disaggregation of Revenue - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Revenue $ 15,730,113 $ 16,674,759
Specialty Food Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenue 13,993,565 13,804,785
Ecommerce [Member]    
Disaggregation of Revenue [Line Items]    
Revenue 1,528,337 2,621,405
Warehouse and Logistic Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenue $ 208,211 $ 248,569
v3.24.1.1.u2
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares - $ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Number of Options 610,000 2,200,000
Weighted Average Remaining Contractual Life (years) 1 year 3 months 7 days 10 months 13 days
Options at $0.41 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price $ 0.41 $ 0.41
Number of Options 125,000 125,000
Weighted Average Remaining Contractual Life (years) 25 days 1 year 25 days
Options at $0.50 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price $ 0.5 $ 0.5
Number of Options 125,000 125,000
Weighted Average Remaining Contractual Life (years) 25 days 1 year 25 days
Options at $0.60 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price $ 0.6 $ 0.6
Number of Options 50,000 50,000
Weighted Average Remaining Contractual Life (years) 1 year 9 months 2 years 9 months
Options at $1.00 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price $ 1 $ 1
Number of Options 50,000 50,000
Weighted Average Remaining Contractual Life (years) 1 year 9 months 2 years 9 months
Options at $1.25 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price $ 1.25  
Number of Options 130,000  
Weighted Average Remaining Contractual Life (years) 2 years 3 months  
Options at $1.75 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price $ 1.75  
Number of Options 130,000  
Weighted Average Remaining Contractual Life (years) 2 years 3 months  
Options at $0.62 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price   $ 0.62
Number of Options   360,000
Weighted Average Remaining Contractual Life (years)   9 months
Options at $0.85 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price   $ 0.85
Number of Options   540,000
Weighted Average Remaining Contractual Life (years)   9 months
Options at $1.20 [Member]    
NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Dilutive Shares [Line Items]    
Exercise Price   $ 1.2
Number of Options   950,000
Weighted Average Remaining Contractual Life (years)   8 months 26 days
v3.24.1.1.u2
DISCONTINUED OPERATIONS (Details) - Disposal Groups, Including Discontinued Operations - Discontinued Operations [Member] - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Cash $ 19,973   $ 95,319
Accounts receivable 635   501
Inventory 41   41
Other current assets 0   0
Total current assets - discontinued operations 20,649   95,861
Accounts payable and accrued liabilities 0   986
Accrued payroll and related liabilities 0   3,267
Deferred revenue 2,522   2,169
Total current liabilities - discontinued operations 2,522   $ 6,422
Revenue 24,856 $ 320,441  
Cost of goods sold (2,238) (8,080)  
Gross margin 22,618 312,361  
Selling, general, and administrative expenses (32,723) (354,692)  
Interest income 0 280  
Loss from discontinued operations, net of tax $ (10,105) $ (42,051)  
v3.24.1.1.u2
SALE OF SUBSIDIARY (Details) - USD ($)
Feb. 26, 2024
Mar. 31, 2024
SALE OF SUBSIDIARY (Details) [Line Items]    
Stock Issued During Period, Shares, Acquisitions 21,126  
Share Price (in Dollars per share) $ 1 $ 1
Income (Loss) from Subsidiaries, Net of Tax (in Dollars) $ 21,126  
Haley Food Group, Inc. [Member]    
SALE OF SUBSIDIARY (Details) [Line Items]    
Subsidiary, Ownership Percentage, Parent 100.00%  
Stock Repurchased During Period, Shares 21,126  
v3.24.1.1.u2
ACCOUNTS RECEIVABLE (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Receivables [Abstract]    
Accounts Receivable, Credit Loss Expense (Reversal) $ 22,882 $ 4,666
v3.24.1.1.u2
ACCOUNTS RECEIVABLE (Details) - Schedule of accounts receivable - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Schedule Of Accounts Receivable Abstract      
Accounts receivable from customers $ 4,178,633   $ 4,354,203
Allowance for doubtful accounts (69,359)   (46,477)
Accounts receivable, net $ 4,109,274 $ 4,307,726 $ 4,307,726
v3.24.1.1.u2
INVENTORY (Details) - Schedule of Inventory - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Schedule Of Inventory Abstract    
Finished goods inventory $ 2,840,682 $ 2,973,134
Allowance for slow moving & obsolete inventory 0 0
Finished goods inventory, net $ 2,840,682 $ 2,973,134
v3.24.1.1.u2
PROPERTY AND EQUIPMENT (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Property, Plant and Equipment [Abstract]    
Depreciation $ 85,345 $ 101,576
Payments to Acquire Property, Plant, and Equipment $ 1,406 $ 7,995
v3.24.1.1.u2
PROPERTY AND EQUIPMENT (Details) - Schedule of property, plant and equipment - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross $ 2,995,194 $ 9,725,245
Less: accumulated depreciation (2,021,051) (2,725,230)
Total 974,143 7,000,015
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 208,140 1,079,512
Building [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 711,409 6,571,496
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 599,242 597,834
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 477,090 477,090
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 940,960 940,960
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross $ 58,353 $ 58,353
v3.24.1.1.u2
PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE (Details) - Race Track Road Property [Member]
Feb. 14, 2024
USD ($)
PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE (Details) [Line Items]  
Proceeds from Sale, Property, Held-for-Sale $ 2,455,000
Gain (Loss) on Disposition of Property Plant Equipment 1,807,516
Payments to Acquire Property, Plant, and Equipment 353,815
Expenses related to sale of Property 165,755
Sales Commissions and Fees 147,300
Excise and Sales Taxes 17,185
Clearance Fees $ 1,270
v3.24.1.1.u2
PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE (Details) - Disclosure of Long-Lived Assets Held-for-Sale - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Long-Lived Assets Held-for-Sale [Line Items]    
Assets held for sale $ 5,941,933 $ 649,844
Land [Member]    
Long-Lived Assets Held-for-Sale [Line Items]    
Assets held for sale 871,372 177,383
Building [Member]    
Long-Lived Assets Held-for-Sale [Line Items]    
Assets held for sale 5,070,561 431,147
Furniture and Fixtures [Member]    
Long-Lived Assets Held-for-Sale [Line Items]    
Assets held for sale $ 0 $ 41,314
v3.24.1.1.u2
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) [Line Items]    
Operating Lease, Expense $ 8,165 $ 18,790
Operating Lease, Right-of-Use Asset, Periodic Reduction $ 4,175 $ 16,314
Minimum [Member]    
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) [Line Items]    
Lessee, Operating Lease, Term of Contract 1 year  
Maximum [Member]    
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) [Line Items]    
Lessee, Operating Lease, Term of Contract 3 years  
v3.24.1.1.u2
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - Schedule of Property Subject to or Available for Operating Lease - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Right to use assets, net $ 24,344 $ 28,519
Equipment [Member]    
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Right to use assets, net 18,477 21,869
Office Equipment [Member]    
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Right to use assets, net $ 5,867 $ 6,650
v3.24.1.1.u2
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - Lease, Cost - USD ($)
Mar. 31, 2024
Dec. 31, 2023
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - Lease, Cost [Line Items]    
Lease liability $ 24,344 $ 28,519
Less: current portion (17,422) (17,131)
Lease liability, non-current 6,922 11,388
Equipment [Member]    
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - Lease, Cost [Line Items]    
Lease liability 18,477 21,869
Office Equipment [Member]    
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - Lease, Cost [Line Items]    
Lease liability $ 5,867 $ 6,650
v3.24.1.1.u2
RIGHT OF USE (“ROU”) ASSETS AND LEASE LIABILITIES – OPERATING LEASES (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Lessee Operating Lease Liability Maturity Abstract    
For the period ended March 31, 2025 $ 18,532  
For the period ended March 31, 2026 7,051  
Total 25,583  
Less: Present value discount (1,239)  
Lease liability $ 24,344 $ 28,519
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disclosure Text Block [Abstract]    
Finance Lease, Right-of-Use Asset, Amortization $ 24,915 $ 33,480
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Lease, Cost - USD ($)
Mar. 31, 2024
Dec. 31, 2023
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Lease, Cost [Line Items]    
Leased Assets, Gross $ 960,274 $ 960,274
Less: accumulated depreciation (548,786) (523,871)
Total 411,488 436,403
Vehicles [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Lease, Cost [Line Items]    
Leased Assets, Gross 404,858 404,858
Equipment [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Lease, Cost [Line Items]    
Leased Assets, Gross $ 555,416 $ 555,416
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease - USD ($)
Mar. 31, 2024
Dec. 31, 2023
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations $ 285,027 $ 335,004
Current portion 136,096 115,738
Long-term maturities 148,931 219,266
Finance Lease #6 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations 1,453 2,884
Finance Lease #5 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations 526 1,044
Finance Lease #1 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations 170,712 197,707
Finance Lease #2 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations 70,666 76,218
Finance Lease #3 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations 11,388 18,035
Finance Lease #4 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations 30,282 33,322
Finance Lease #7 [Member]    
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease [Line Items]    
Financing lease obligations $ 0 $ 5,794
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) - USD ($)
3 Months Ended
Feb. 04, 2022
Jul. 15, 2021
Jul. 12, 2021
Oct. 14, 2020
Mar. 31, 2020
Aug. 23, 2019
Nov. 05, 2018
Mar. 31, 2024
Finance Lease #6 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount     $ 16,070          
Payable     thirty-six monthly installments of $489          
Interest Rate     6.01%          
Principal payments               $ 1,431
Interest Payments               36
Finance Lease #5 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount   $ 5,816            
Payable   thirty-six monthly installments of $177            
Interest Rate   6.01%            
Principal payments               518
Interest Payments               13
Finance Lease #1 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount       $ 514,173        
Payable       sixty monthly installments of $9,942        
Interest Rate       6.01%        
Principal payments               19,084
Interest Payments               2,834
Finance Lease #2 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount         $ 152,548      
Payable         eighty-four monthly installments of $2,188      
Interest Rate         5.44%      
Principal payments               5,552
Interest Payments               1,012
Finance Lease #3 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount             $ 128,587  
Payable             seventy monthly installments of $2,326  
Interest Rate             8.33%  
Principal payments               6,647
Interest Payments               330
Finance Lease #4 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount           $ 80,413    
Payable           eighty-four monthly installments of $1,148    
Interest Rate           5.00%    
Principal payments               3,040
Interest Payments               404
Finance Lease #7 [Member]                
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease (Parentheticals) [Line Items]                
Original amount $ 42,500              
Payable twenty-four monthly installments of $1,963              
Interest Rate 10.10%              
Principal payments               5,794
Interest Payments               $ 98
v3.24.1.1.u2
RIGHT OF USE ASSETS – FINANCING LEASES (Details) - Finance Lease, Liability, Maturity
Mar. 31, 2024
USD ($)
Finance Lease Liability Maturity Abstract  
2025 $ 160,993
2026 96,060
2027 27,974
Total $ 285,027
v3.24.1.1.u2
INTANGIBLE ASSETS (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
INTANGIBLE ASSETS (Details) [Line Items]    
Amortization of Intangible Assets $ 0 $ 0
Artisan [Member]    
INTANGIBLE ASSETS (Details) [Line Items]    
Other Intangible Assets, Net $ 217,000  
v3.24.1.1.u2
INTANGIBLE ASSETS (Details) - Schedule of intangible assets - Trade Names [Member] - USD ($)
Mar. 31, 2024
Dec. 31, 2023
INTANGIBLE ASSETS (Details) - Schedule of intangible assets [Line Items]    
Intangible asset, gross $ 217,000 $ 217,000
Intangible asset, Accumulated Amortization 0 0
Intangible asset, Net $ 217,000 $ 217,000
v3.24.1.1.u2
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of accounts payable and accrued liabilities - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Schedule Of Accounts Payable And Accrued Liabilities Abstract    
Trade payables and accrued liabilities $ 2,955,157 $ 6,046,396
Accrued payroll and commissions 156,514 206,555
Total $ 3,111,671 $ 6,252,951
v3.24.1.1.u2
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) - USD ($)
3 Months Ended 4 Months Ended
Feb. 06, 2024
Feb. 28, 2023
Feb. 03, 2023
Mar. 31, 2024
Mar. 31, 2023
Jul. 01, 2024
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs     $ 250,000 $ (947,736)    
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture         $ 45,680  
Severance Costs       0 $ 1,945,650  
Former CEO And Director [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       (776,975)    
Debt Instrument, Face Amount     1,000,000      
Debt Instrument, Periodic Payment     $ 6,410.26      
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in Shares)     400,000      
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture     $ 168,000      
Severance Costs       1,819,199    
Former CEO And Director [Member] | Shares To Be Delivered On June 1, 2027 [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       0    
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in Shares)     266,666      
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture     $ 400,000      
Former CEO And Director [Member] | Insurance, Other [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       0    
Severance Costs     $ 1,199      
Former CEO And Director [Member] | Payment Due Upon Execution Of Agreement [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       (250,000)    
Director of Strategic Acquisitions [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       (126,451)    
Severance Costs   $ 100,000   126,451    
Insurance Payments Monthly   2,548        
Director of Strategic Acquisitions [Member] | Insurance, Other [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       (26,451)    
Severance Costs   26,451        
Director of Strategic Acquisitions [Member] | Payment Due Upon Execution Of Agreement [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs   33,333   (100,000)    
Director of Strategic Acquisitions [Member] | Payment Due March 15, 2023 [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs   33,333        
Director of Strategic Acquisitions [Member] | Payment Due On April 15, 2023 [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs   $ 33,334        
Richard Tang [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Severance Costs $ 113,918          
Richard Tang [Member] | Legal Fees [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Severance Costs 4,000          
Richard Tang [Member] | Payment Due March 4, 2024 [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs $ 25,890          
Richard Tang [Member] | Payment Due March 11, 2024 [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs           $ 5,178
Mr. Klepfish [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       83,333    
Mr. Wiernasz [Member] | Insurance, Other [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       967    
Mr. Tang [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       41,125    
Mr. Tang [Member] | Insurance, Other [Member]            
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) [Line Items]            
Payments Of Separation Costs       $ 2,885    
v3.24.1.1.u2
ACCRUED SEPARATION COSTS – RELATED PARTIES (Details) - Schedule of Related Party Transactions - USD ($)
3 Months Ended
Feb. 28, 2023
Feb. 03, 2023
Mar. 31, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]        
Total     $ 2,074,063  
Paid / Issued   $ 250,000 (947,736)  
Balance     1,126,327  
Current     418,635 $ 463,911
Non-current     707,692  
Former CEO And Director [Member]        
Related Party Transaction [Line Items]        
Total     1,819,199  
Paid / Issued     (776,975)  
Balance     1,042,224  
Current     334,532  
Non-current     707,692  
Former CEO And Director [Member] | Cash Payment Due March 6, 2026 [Member]        
Related Party Transaction [Line Items]        
Total     1,000,000  
Paid / Issued     (358,975)  
Balance     641,025  
Current     333,333  
Non-current     307,692  
Former CEO And Director [Member] | Payment Due Upon Execution Of Agreement [Member]        
Related Party Transaction [Line Items]        
Total     250,000  
Paid / Issued     (250,000)  
Balance     0  
Current     0  
Non-current     0  
Former CEO And Director [Member] | Shares To Be Delivered On June 1, 2027 [Member]        
Related Party Transaction [Line Items]        
Total     400,000  
Paid / Issued     0  
Balance     400,000  
Current     0  
Non-current     400,000  
Former CEO And Director [Member] | Shares Issued April 2023 [Member]        
Related Party Transaction [Line Items]        
Total     168,000  
Paid / Issued     (168,000)  
Balance     0  
Current     0  
Non-current     0  
Former CEO And Director [Member] | Insurance, Other [Member]        
Related Party Transaction [Line Items]        
Total     1,199  
Paid / Issued     0  
Balance     1,199  
Current     1,199  
Non-current     0  
Director of Strategic Acquisitions [Member]        
Related Party Transaction [Line Items]        
Total     126,451  
Paid / Issued     (126,451)  
Balance     0  
Current     0  
Non-current     0  
Director of Strategic Acquisitions [Member] | Payment Due Upon Execution Of Agreement [Member]        
Related Party Transaction [Line Items]        
Total     100,000  
Paid / Issued $ 33,333   (100,000)  
Balance     0  
Current     0  
Non-current     0  
Director of Strategic Acquisitions [Member] | Insurance, Other [Member]        
Related Party Transaction [Line Items]        
Total     26,451  
Paid / Issued     (26,451)  
Balance     0  
Current     0  
Non-current     0  
Chief Financial Officer [Member]        
Related Party Transaction [Line Items]        
Total     128,413  
Paid / Issued     (44,310)  
Balance     84,103  
Current     84,103  
Non-current     0  
Chief Financial Officer [Member] | Payment Due Upon Execution Of Agreement [Member]        
Related Party Transaction [Line Items]        
Total     113,918  
Paid / Issued     (41,425)  
Balance     72,493  
Current     72,493  
Non-current     0  
Chief Financial Officer [Member] | Insurance, Other [Member]        
Related Party Transaction [Line Items]        
Total     14,495  
Paid / Issued     (2,885)  
Balance     11,610  
Current     11,610  
Non-current     $ 0  
v3.24.1.1.u2
STOCK APPRECIATION RIGHTS LIABILITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
3 Months Ended
May 15, 2023
Mar. 31, 2024
STOCK APPRECIATION RIGHTS LIABILITY (Details) [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period 1,500,000  
Share-Based Payment Arrangement, Noncash Expense $ 9,794 $ 118,898
v3.24.1.1.u2
STOCK APPRECIATION RIGHTS LIABILITY (Details) - Change in valuation of stock appreciation rights - Stock Appreciation Rights (SARs) [Member] - USD ($)
3 Months Ended 8 Months Ended
Mar. 31, 2024
Dec. 31, 2023
STOCK APPRECIATION RIGHTS LIABILITY (Details) - Change in valuation of stock appreciation rights [Line Items]    
Balance $ 255,020 $ 9,794
(Gain) Loss on revaluation 118,898 245,226
Balance $ 373,918 $ 255,020
v3.24.1.1.u2
NOTES PAYABLE (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Interest Payable $ 93,829 $ 95,942
v3.24.1.1.u2
NOTES PAYABLE (Details) - Schedule of debt - USD ($)
Mar. 31, 2024
Dec. 31, 2023
NOTES PAYABLE (Details) - Schedule of debt [Line Items]    
Notes payable $ 8,982,933 $ 9,358,547
Discount (381,222) (382,506)
Total, net of discount 8,601,711 8,976,041
Current portion 100,237 121,041
Long-term maturities 8,501,474 8,855,000
Maple Mark Term Loan 3 [Member]    
NOTES PAYABLE (Details) - Schedule of debt [Line Items]    
Notes payable 8,962,933 8,985,642
Maple Mark Term Loan 2 [Member]    
NOTES PAYABLE (Details) - Schedule of debt [Line Items]    
Notes payable 0 352,905
Convertible Debt [Member]    
NOTES PAYABLE (Details) - Schedule of debt [Line Items]    
Convertible Note Payable $ 20,000 $ 20,000
v3.24.1.1.u2
NOTES PAYABLE (Details) - Schedule of debt (Parentheticals) - USD ($)
3 Months Ended 125 Months Ended 305 Months Ended
Jun. 13, 2023
Jun. 09, 2023
Jun. 06, 2022
Mar. 31, 2024
Mar. 31, 2023
Jun. 01, 2033
Jun. 13, 2048
Dec. 31, 2023
Dec. 31, 2022
NOTES PAYABLE (Details) - Schedule of debt (Parentheticals) [Line Items]                  
Discount       $ 1,283 $ 0        
Principal payments       22,708 $ 2,757        
accrued interest       $ 93,829       $ 95,942  
Maple Mark Term Loan 3 [Member]                  
NOTES PAYABLE (Details) - Schedule of debt (Parentheticals) [Line Items]                  
Amount $ 9,057,840                
            $ 80,025    
June 13, 2048                
Interest rate Amounts outstanding under the Maple Mark Term Loan 3 will bear interest at the rate equal to the lesser of (a) the Maximum Lawful Rate, or (b) the greater of (i) WSJP (the “Prime Rate” as published by The Wall Street Journal) plus 1.25% per annum or (ii) 4.50% per annum. At March 31, 2024, the interest rate was 9.50%. The MapleMark Term Loan 3 matures on June 13, 2048.                
Interest       9.50%          
Discount $ 385,803     $ 1,284          
      221,317          
accrued interest       75,251          
Maple Mark Term Loan 3 [Member] | Principal [Member]                  
NOTES PAYABLE (Details) - Schedule of debt (Parentheticals) [Line Items]                  
Principal payments       22,709          
Maple Mark Term Loan 2 [Member]                  
NOTES PAYABLE (Details) - Schedule of debt (Parentheticals) [Line Items]                  
Amount     $ 356,800            
          $ 2,311      
  May 27, 2033              
Discount     $ 23,367            
Principal payments       352,905          
      910          
Final payment   $ 303,536              
                $ 23,367
Convertible Debt [Member]                  
NOTES PAYABLE (Details) - Schedule of debt (Parentheticals) [Line Items]                  
Amount       $ 20,000          
Interest       1.90%          
      $ 96          
accrued interest       $ 18,578          
v3.24.1.1.u2
NOTES PAYABLE (Details) - Schedule of Maturities of Long-Term Debt
Mar. 31, 2024
USD ($)
Schedule Of Maturities Of Long Term Debt Abstract  
2025 $ 120,237
2026 110,532
2027 121,884
2028 134,403
2029 148,207
Thereafter 8,347,670
Total $ 8,982,933
v3.24.1.1.u2
EQUITY (Details)
3 Months Ended
Feb. 26, 2024
USD ($)
$ / shares
shares
Jan. 01, 2024
USD ($)
Nov. 07, 2023
shares
May 15, 2023
USD ($)
$ / shares
shares
Feb. 28, 2023
USD ($)
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
shares
Mar. 19, 2024
USD ($)
Dec. 31, 2023
shares
EQUITY (Details) [Line Items]                  
Common Stock, Shares, Issued (in Shares) | shares           52,516,974     52,538,100
Common Stock, Shares, Outstanding (in Shares) | shares           49,693,803     49,714,929
Common Stock Issued, but not Outstanding (in Shares) | shares                 2,823,171
Stock Issued During Period, Shares, Acquisitions (in Shares) | shares 21,126                
Share Price (in Dollars per share) | $ / shares $ 1         $ 1      
Income (Loss) from Subsidiaries, Net of Tax $ 21,126                
Stock Issued During Period, Value, Issued for Services         $ 112,152   $ 112,142    
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture             $ 45,680    
Stock Issued During Period, Shares, New Issues (in Shares) | shares     678,302            
NumberOfDirectors             2    
Share-Based Payment Arrangement, Expense             $ 52,919    
Share-Based Payment Arrangement, Noncash Expense           $ 103,235 $ 178,048    
Haley Food Group, Inc. [Member]                  
EQUITY (Details) [Line Items]                  
Subsidiary, Ownership Percentage, Parent 100.00%                
Stock Repurchased During Period, Shares (in Shares) | shares 21,126                
Mr. Bennett [Member]                  
EQUITY (Details) [Line Items]                  
Common Stock Issued, but not Outstanding (in Shares) | shares           2,823,171      
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable               $ 731,350  
Previous CFO [Member]                  
EQUITY (Details) [Line Items]                  
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares         267,030        
Previous CEO [Member]                  
EQUITY (Details) [Line Items]                  
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in Shares) | shares             400,007    
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture             $ 93,600    
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in Shares) | shares             207,839    
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation             $ 52,919    
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in Shares) | shares             192,168    
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture             $ 45,680    
Chief Executive Officer [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in Shares) | shares     296,831            
Restricted Stock [Member] | Minimum [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period             1 year    
Restricted Stock [Member] | Maximum [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period             3 years    
Stock Appreciation Rights (SARs) [Member]                  
EQUITY (Details) [Line Items]                  
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture           $ 373,918      
Share-Based Payment Arrangement, Noncash Expense       $ 9,794   118,898      
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in Shares) | shares       1,500,000          
SARs Priced At150 [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in Shares) | shares       750,000          
Shares Issued, Price Per Share (in Dollars per share) | $ / shares       $ 1.5          
SARs Priced At200 [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in Shares) | shares       750,000          
Shares Issued, Price Per Share (in Dollars per share) | $ / shares       $ 2          
Share-Based Payment Arrangement, Option [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Payment Arrangement, Expense           2,034 $ 0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value           $ 156,075      
Officers and directors [Member]                  
EQUITY (Details) [Line Items]                  
Stock Issued During Period, Shares, New Issues (in Shares) | shares             15,106    
Stock Issued During Period, Value, New Issues             $ 5,000    
Chief Executive Officer [Member]                  
EQUITY (Details) [Line Items]                  
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture (in Shares) | shares           3,910,534 3,538,243    
Share-Based Payment Arrangement, Expense           $ 58,283 $ 19,428    
Share-Based Payment Arrangement, Amount Capitalized           660,541      
Chief Operating Officer [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Payment Arrangement, Expense           19,043      
Share-Based Payment Arrangement, Amount Capitalized       $ 199,951          
Chief Financial Officer [Member]                  
EQUITY (Details) [Line Items]                  
Share-Based Payment Arrangement, Expense           $ 23,875      
Share-Based Payment Arrangement, Amount Capitalized   $ 238,747              
v3.24.1.1.u2
EQUITY (Details) - Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Stock Price Target 0.60 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 0.6
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 2.00%
Maximum Number Of Shares | shares 975,133
Stock Price Target 0.80 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 0.8
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 1.50%
Maximum Number Of Shares | shares 731,350
Stock Price Target 1.00 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 1.00%
Maximum Number Of Shares | shares 487,567
Stock Price Target 1.20 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.2
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.75%
Maximum Number Of Shares | shares 365,675
Stock Price Target 1.40 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.4
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.75%
Maximum Number Of Shares | shares 365,675
Stock Price Target 1.60 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.6
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.50%
Maximum Number Of Shares | shares 243,783
Stock Price Target 1.80 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.8
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.50%
Maximum Number Of Shares | shares 243,783
Stock Price Target 2.00 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.50%
Maximum Number Of Shares | shares 243,783
v3.24.1.1.u2
EQUITY (Details) - Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Stock Price Target 0.87 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 0.87
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.40%
Maximum Number Of Shares | shares 196,627
Stock Price Target 1.16 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.16
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.30%
Maximum Number Of Shares | shares 147,470
Stock Price Target 1.45 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.45
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.20%
Maximum Number Of Shares | shares 98,313
Stock Price Target 1.74 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.74
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.15%
Maximum Number Of Shares | shares 73,735
Stock Price Target 2.03 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.03
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.15%
Maximum Number Of Shares | shares 73,735
Stock Price Target 2.32 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.32
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.10%
Maximum Number Of Shares | shares 49,157
Stock Price Target 2.61 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.61
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.10%
Maximum Number Of Shares | shares 49,157
Stock Price Target 2.90 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.9
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.10%
Maximum Number Of Shares | shares 49,157
v3.24.1.1.u2
EQUITY (Details) - Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Stock Price Target 1.23 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.23
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.40%
Maximum Number Of Shares | shares 131,085
Stock Price Target 1.63 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 1.63
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.30%
Maximum Number Of Shares | shares 98,313
Stock Price Target 2.04 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.04
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.20%
Maximum Number Of Shares | shares 65,542
Stock Price Target 2.45 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.45
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.15%
Maximum Number Of Shares | shares 49,157
Stock Price Target 2.86 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 2.86
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.15%
Maximum Number Of Shares | shares 49,157
Stock Price Target 3.27 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 3.27
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.10%
Maximum Number Of Shares | shares 32,771
Stock Price Target 3.68 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 3.68
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.10%
Maximum Number Of Shares | shares 32,771
Stock Price Target 4.08 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Price Target | $ / shares $ 4.08
Number Of Shares Issued And Outstanding On Grant Date Multiplied By 0.10%
Maximum Number Of Shares | shares 32,771
v3.24.1.1.u2
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Line Items]    
Dividends (in Dollars)   $ 0
Minimum [Member]    
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Line Items]    
Volatility   103.90%
Risk-free interest rates   4.45%
Term (years)   2 years 7 months 17 days
Maximum [Member]    
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Line Items]    
Volatility   113.70%
Risk-free interest rates   4.45%
Term (years)   2 years 10 months 28 days
Stock Appreciation Rights (SARs) [Member]    
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Line Items]    
Volatility 86.58%  
Dividends (in Dollars) $ 0 $ 0
Risk-free interest rates 4.59%  
Term (years) 2 years 9 months  
Stock Appreciation Rights (SARs) [Member] | Minimum [Member]    
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Line Items]    
Volatility   45.00%
Risk-free interest rates   3.67%
Term (years)   2 years 7 months 17 days
Stock Appreciation Rights (SARs) [Member] | Maximum [Member]    
EQUITY (Details) - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Line Items]    
Volatility   53.30%
Risk-free interest rates   4.87%
Term (years)   2 years 6 months 3 days
v3.24.1.1.u2
EQUITY (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range - Share-Based Payment Arrangement, Option [Member] - $ / shares
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Number of options outstanding (in Shares) 610,000 350,000
Weighted average remaining contractual life 1 year 3 months 7 days  
Weighted average exercise price of options outstanding $ 0.96 $ 0.55
Number of options exercisable (in Shares) 350,000  
Weighted average exercise price of options exercisable $ 0.55  
Options at $0.41 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise prices $ 0.41  
Number of options outstanding (in Shares) 125,000  
Weighted average remaining contractual life 25 days  
Weighted average exercise price of options outstanding $ 0.41  
Number of options exercisable (in Shares) 125,000  
Weighted average exercise price of options exercisable $ 0.41  
Options at $0.50 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise prices $ 0.5  
Number of options outstanding (in Shares) 125,000  
Weighted average remaining contractual life 25 days  
Weighted average exercise price of options outstanding $ 0.5  
Number of options exercisable (in Shares) 125,000  
Weighted average exercise price of options exercisable $ 0.5  
Options at $0.60 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise prices $ 0.6  
Number of options outstanding (in Shares) 50,000  
Weighted average remaining contractual life 1 year 9 months  
Weighted average exercise price of options outstanding $ 0.6  
Number of options exercisable (in Shares) 43,750  
Weighted average exercise price of options exercisable $ 0.6  
Options at $1.00 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise prices $ 1  
Number of options outstanding (in Shares) 50,000  
Weighted average remaining contractual life 1 year 9 months  
Weighted average exercise price of options outstanding $ 1  
Number of options exercisable (in Shares) 43,750  
Weighted average exercise price of options exercisable $ 1  
Options at $1.25 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise prices $ 1.25  
Number of options outstanding (in Shares) 130,000  
Weighted average remaining contractual life 2 years 3 months  
Weighted average exercise price of options outstanding $ 1.25  
Number of options exercisable (in Shares) 0  
Weighted average exercise price of options exercisable $ 0  
Options at $1.75 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise prices $ 1.75  
Number of options outstanding (in Shares) 130,000  
Weighted average remaining contractual life 2 years 3 months  
Weighted average exercise price of options outstanding $ 1.75  
Number of options exercisable (in Shares) 0  
Weighted average exercise price of options exercisable $ 0  
v3.24.1.1.u2
EQUITY (Details) - Schedule of share-based compensation, stock options, activity - Share-Based Payment Arrangement, Option [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
EQUITY (Details) - Schedule of share-based compensation, stock options, activity [Line Items]  
Options Outstanding | shares 350,000
Options Outstanding, Weighted Average Exercise Price | $ / shares $ 0.55
Options Exercisable | shares 350,000
Options Exercisable, Weighted Average Exercise Price | $ / shares $ 0.55
Options Issued | shares 260,000
Options Issued, Weighted Average Exercise Price | $ / shares $ 1.5
Options Exercised | shares 0
Options Exercised, Weighted Average Exercise Price | $ / shares $ 0
Options Forfeited or expired | shares 0
Options Forfeited or expired, Weighted Average Exercise Price | $ / shares $ 0
Options Outstanding | shares 610,000
Options Outstanding, Weighted Average Exercise Price | $ / shares $ 0.96
v3.24.1.1.u2
RELATED PARTY TRANSACTIONS (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
Mr. Klepfish [Member]  
RELATED PARTY TRANSACTIONS (Details) [Line Items]  
Payments Of Separation Costs $ 83,333
Mr. Wiernasz [Member] | Insurance, Other [Member]  
RELATED PARTY TRANSACTIONS (Details) [Line Items]  
Payments Of Separation Costs 967
Mr. Tang [Member]  
RELATED PARTY TRANSACTIONS (Details) [Line Items]  
Payments Of Separation Costs 41,125
Mr. Tang [Member] | Insurance, Other [Member]  
RELATED PARTY TRANSACTIONS (Details) [Line Items]  
Payments Of Separation Costs $ 2,885
v3.24.1.1.u2
MAJOR CUSTOMERS (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
U.S. Foods, Inc. [Member]    
MAJOR CUSTOMERS (Details) [Line Items]    
Concentration Risk, Percentage 49.00% 47.00%
Gate Gourmet [Member]    
MAJOR CUSTOMERS (Details) [Line Items]    
Concentration Risk, Percentage 17.00% 16.00%
v3.24.1.1.u2
SUBSEQUENT EVENTS (Details)
Apr. 17, 2024
Performance Shares [Member] | Subsequent Event [Member]  
SUBSEQUENT EVENTS (Details) [Line Items]  
Share-Based Compensation Arrangement by Share-Based Payment Award, Description the Company’s stock price achieved the first price target of $0.87 under the COO Stock Plan and the Company became obligated to issue a total of 196,627 shares to its COO.

Innovative Food (QB) (USOTC:IVFH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Innovative Food (QB) Charts.
Innovative Food (QB) (USOTC:IVFH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Innovative Food (QB) Charts.